











Title of Document: THE DEVELOPMENT OF NEW TOOLS FOR 
THE INVESTIGATION OF PROTEIN 
FUNCTION USING PHOTO-REACTIVE 
UNNATURAL AMINO ACIDS.   
  
 Bryan Jason Wilkins, Doctor of Philosophy, 
2010 
  




Reported here is the direct synthesis and application of unnatural amino acids 
for the development of exploratory tools for protein studies.  This work takes 
advantage of an expanded genetic code to extract a more precise chemical 
understanding of protein function with novel additions to the unnatural amino acid 
catalogue, as well as the expansion of techniques with previously developed 
compounds.  The photochemical crosslinker, [D11]-p-benzoylphenylalanine (pBpa), is 
synthesized for isotopic labeling in proteins.  When [D11]-pBpa is co-incorporated 
into protein with [D0]-pBpa it is a mass spectral tool for rapid and conclusive 
identification of crosslinked fragments.  Following enzymatic digestion the 
fingerprint of M, M+ 11 is readily identified allowing for rapid peak identification 
and the determined site of crosslink formation with single amino acid accuracy.  In a 
means to extract a level of spatiotemporal control over fluorescent labeling of protein, 
  
the photo-protected unnatural amino acid, o-nitrobenzyl cysteine (ONBC), is 
introduced to a small amino acid tag sequence CCPGCC.  This tag is required and 
specifically binds the pro-fluorescent compound 5-bis(1,3,2-dithiasolan-2-
yl)fluorescein (FlAsH).  This work takes advantage of the inability of FlAsH to bind 
the cysteine-tag motif in the presence of an ONBC mutation.  The photo-protected 
amino acid is deprotected with light, affording natural cysteine and the successful 
binding of FlasH to the tetracysteine tag only following ultraviolet irradiation.  
Finally, fluorinated tyrosine derivatives are synthetically modified to contain photo-
protecting groups, which act as a disguise during unnatural amino acid mutagenesis 
techniques.  Fluorinated tyrosines are recognized by endogenous tyrosyl-tRNA 
synthetases and incorporated globally throughout a protein at tyrosine positions.  To 
circumvent this problem the o-nitrobenzyl photo-protecting group is installed on the 
tyrosine derivatives 2-fluorotyrosine, 3-fluorotyrosine, and 2,6-difluorotyrosine.  The 
directed evolution of an orthogonal amber-tRNA synthetase, specific for these 
unnatural amino acids, is performed, providing the translational machinery for site-
specific incorporation of these compounds.  Following expression of protein with the 
protected tyrosine derivatives, protein exposed to ultraviolet irradiation subsequently 
loses the protecting group affording the site-specific incorporation of fluorinated 
tyrosine.  Fluorinated tyrosines are introduced to the critical trysoine residue in the 
chromophore of super-folder green fluorescent protein to determine how the altered 
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Chapter 1: Introduction 
 
Understanding the structure and function of proteins is one of the most heavily 
studied disciplines of biochemistry.  Biological systems rely on an infrastructure of vast 
assemblies of complex networks that operate on a multitude of levels.  At the base of this 
scaffolding lies an atomic network where simple molecules, such as amino acids and 
nucleotides, act as the monomeric subunits of larger macromolecules, including proteins 
and DNA, respectively.  In the case of proteins, the arrangement of amino acids and their 
atomic interactions within the configuration dictate folding patterns and overall structure 
and function.  A single amino acid mutation, deletion, or repeat can alter conformation, 
causing structural defects that modify or destroy the native function of the protein.  
Where proteins are only one facet of a large biological realm, biochemistry attempts to 
explain the underlying basis of biomolecular assemblies, exposing their structure and 
function through chemical mechanisms that ultimately fashion all living organisms. 
Chemical biology is a specialized discipline that sits at the interface of chemistry 
and biology, approaching biological issues from a chemical prospective.  While this may 
sound synonymous with biochemistry, it differs in the fact that chemical synthesis is 
often employed for the design and implementation of small molecules to manipulate a 
system to help elucidate its biological importance.  This field revolves around the 
development of techniques that uniquely address questions in biology, where each new 
small molecule, or probe, is an addition to a molecular “toolbox” for biochemical 




molecular biology, focusing on the application of synthesized molecules for the 
perturbation of chemical environments within protein.  While the scope of chemical 
biology spans a vast assortment of chemical explorations, this dissertation will focus on 
the synthesis and application of unnatural amino acids as a defined chemical approach 
with which to investigate protein function. 
1.1 Unnatural amino acids 
The genetic code of all living organisms is a template by which protein assembly 
is based.  This sequenced code of nucleotides in RNA is translated through ribosomal 
machinery yielding a polymeric peptide chain.  The construction of all protein is carried 
out using the same 20 naturally occurring amino acids, with the addition of 
selenocysteine3 and pyrrolysine4, considered to be the 21st and 22nd natural amino acids, 
respectively.  While evolution has dictated that this small set of building blocks is 
sufficient to maintain life, the side chain chemistries have a finite number of 
functionalities.  In many instances, the chemistries introduced are not adequate to carry 
out their natural intended function, dependent upon post-translational modifications, 
providing irregular amino acids5-10.  This limitation is more obvious for biochemical 
assays, where the conventional approach to probing protein function is based on site-
directed mutagenesis.  Restrictions are placed on the available functionality by the 
limited number of  amino acids provided in nature.   
Chemistry allows for an almost infinite number of chemically synthesized amino 
acids that contain unnatural side chains.  The direct perturbation of specific amino acids 
aids in the elucidation of structure-function relationships, as well as in the generation of 




greatly augments the ability to focus on specific biological questions.  The implication 
that any non-native functional group can be generated and in turn engineered into protein, 
provides the basis for the development of strategies which genetically incorporate these 
compounds into an expanded genetic code.  
1.1.1 Current applications of non-natural amino acids in biological studies 
 While there have been several approaches developed to incorporate unnatural 
amino acids (UAA) into protein, this section will focus primarily on the successes and 
advances toward in vivo incorporation of UAAs site-specifically through suppressor 
tRNA machinery (methodology will be discussed in further sections).  Greater than forty 
UAAs have been site-specifically incorporated at the genetic level of Escherichia coli (E. 
coli), Saccharomyces cerevisiae (yeast), and mammalian cells, introducing a myriad of 
new functionality into proteins.   
 Nature does not encode for amino acids which contain highly reactive side chains 
under mild or neutral conditions.  This, of course, is inherent in the processes of cellular 
activity, as most reactions are controlled under strict general acid/based catalyzed 
mechanisms.  Functional groups such as ketones and aldehydes are not prevalent as their 
chemistries would prove over-reactive and fatal to biological function.  This lack of 
reactivity in nature creates a limit on the biosynthetic additions that can be carried out 
due to the unavailability of chemical handles.  UAAs with chemically reactive side chains 
have been introduced to circumvent this limitation.  Examples of ketone moieties having 
been genetically introduced are p-acetylphenylalanine11 (1-1), m-acetylphenylalanine11 
(1-2), and p-(3-oxobutanoyl)-L-phenylalanine12 (1-3).  These new chemical environments 




and without the need for protecting native functional groups.  Specific reactions have 
shown the selectivity of the keto and diketo groups to react with both hydraazides and 
alkoxyamines, and the ability to label these groups with a number of fluorophores11 and 
tags, including the direct addition of polyethylene glycol (PEG)13.  These specific 
examples help illustrate how the introduction of novel chemistry allows for specificity 
along a peptide chain for a desired chemical reaction and the ability to site-specifically 
modify residues of interest.   
Two UAAs have particular applications in the study of protein-protein 
interactions, where their side chain chemistries allow for the ability to chemically 
crosslink protein at interfaces in spatial proximity to the residue.  The UAA p-azido-
phenylalanine (1-4) contains an aryl-azide functional group, which is a photo-activated 
crosslinker14.  When irradiated with light at ~ 310 nm a dehydroazepine is formed which 





Figure 1-1.  Chemical structures of the unnatural amino acids represented in Chapter 1. 
 
Of particular interest to this work is the photo-crosslinking agent p-




group which is activated with light at ~360 nm and reacts irreversibly with adjacent 
carbon-hydrogen bonds (the chemistry and details to be outlined in Chapter 2).  Both of 
these UAAs have the ability to act as powerful in vitro and in vivo probes for potential 
protein-protein interactions.  p-Benzoylphenylalanine has recently been utilized to 
capture important ligand binding events in G-protein coupled receptors in yeast17.  
Another photo-activated UAA is p-azophenyl-phenylalanine (1-6a/b) which can be light 
induced to toggle between geometric isomers18, with the potential to act as a photo-
switch.      
Perhaps one of the most intriguing groups of UAAs are those which contain 
photo-protecting groups.  These moieties are generally termed “caging” groups, and are 
photolysed to afford a native amino acid residue.  The rationale of a caging group is to 
inhibit the natural activity of the amino acid until removed with light.  Inhibition is based 
on the introduction of this group to a critical atom on the amino acid side chain so as to 
block its natural chemical ability.  Photo-caged cysteine19 (1-7) and tyrosine20 (1-8) have 
both been introduced into proteins where the thiol and hydroxyl groups of the prospective 
amino acids were blocked by a nitrobenzyl group.  These caged amino acids were then 
photo-chemically decaged upon irradiation with light at 365 nm.  The photo-caged 
cysteine was specifically introduced at an essential cysteine residue in the cysteine 
dependent protease, caspase 319.  Introduction of the caged variant of cysteine inhibited  
protein activity, which was photo-activated upon irradiation with light.  There is an 
extensive amount of research, and numerous reviews, dedicated to the caged inhibition of 
molecules, in particular, amino acids19, 21-27.  Light activation of critical residues in a 




events, and signaling pathways as this approach introduces a level of spatiotemporal 
control over protein function21, 25, 28-32.  
Each of the above UAAs is a specific case of novel chemistry being introduced at 
the protein level.  Each new addition to the growing number of UAAs that have been 
successfully incorporated into protein allows for a unique probe and extended level of 
insight into biochemical questions relating to protein chemistry.  This work attempts to 
expand the depth of an UAA molecular toolbox by extending the applications of already 
developed UAAs while also developing new UAAs for novel probes in protein 
investigations.                                                   
1.1.2 Caged amino acids 
 While the previous section explored some of the available UAAs used in recent 
studies, this section will narrow that field to those which contain photolabile protecting 
groups, in particular, the o-nitrobenzyl group (ONB).  As stated previously, these groups 
are referred to as “caging” groups and are photo-released when irradiated with 365 nm 
light.  The caging moiety inhibits the native function of the molecule to which it is 
covalently attached.  The caged amino acid is inactive until decaged by light, thereby 
restoring the molecules activity.  In this approach light provides an external control over 
biological function when the caged group is placed on a critical residue involved in 
protein function.  Moreover, light irradiation can be controlled in a spatial and temporal 
fashion providing precise control over processes where location and timing are variables 
which often have distinct biological implications.  
 The first instance of this strategy being applied in a biological context was the 




(ATP)33.  This derivative of ATP was not recognized as a substrate by the ATP dependent 
enzyme Na/K-ATPase, which is responsible for cellular outflow of Na+ ions and the 
influx of K+ ions.  Photolysis released ATP, restoring substrate recognition, and, in turn, 
restoring activity of the ion pump.  This study jump started an appealing movement 
toward biologically active molecules which can act as photo-switches providing direct 
control over cellular events. 
 There is a wide-range of photolabile protecting groups available for the 
application of light activated biomolecules23, 34-36.  Some of the more popular variants are 
derivatives of coumarin (1-9) and ONB (1-10), where nitrobenzyl groups are by far the 
most common (Figure 1-2a) due to the ease by which they can be installed on the 
molecule of interest.  This is especially straightforward in the addition of ONB to amino 
acids with nucleophilic potential, under basic conditions, where simple SN2 type 
reactions occur with compounds such as 2-nitrobenzyl bromide (Figure 1-2b, 1-11), 
which is commercially available.  It is important to note, that the caging group must be 
installed on the atom of functional interest, thereby inhibiting its native chemistry.  For 
example, figure 1-2b illustrates caging at the thiol of a cysteine molecule thereby 
inhibiting its nucleophilic potential while protected.  The decaging mechanism of ONB 
groups also occurs at a relatively low energy wavelength which does not have adverse 
affects on other cellular components.  Herein we will focus on the application of ONB 





Figure 1-2.  a) Commonly used photo-protecting groups:  6-bromo-7-hydroxycoumarin-4-
ylmethyl (1-9) and ONB (1-10).  b) Reaction schematic of the general approach to covalent 
modification of amino acids with 2-nitrobenzylbromide. 
 
The mechanism of photochemical decaging is detailed in Scheme 1-137.  The 
initial excitation of the caged molecule promotes the formation of an aci-nitro tautomer 
(1-12), where the generation of this species occurs in the range of <1 ns23.  The decay of 
1-12 proceeds via 1-13 and the subsequent equilibration to yield the isomeric nitronic 
acid (1-14).  1-14 then continues through a cyclization step forming the bicyclic product 
1-15 which is broken down to form 1-16.  The final step is a base-catalyzed breakdown 
of 1-16.  One of the glaring disadvantages to this approach is the generation of a 
nitrosaldehyde (1-17) which has the potential to be harmful in biological context due to 
its highly reactive functional group.  The base catalyzed reaction mechanism is suggested 
in line with previous studies on the hydrolysis of hemiacetals of acetophenone and its 





Scheme 1-1.  Decaging mechanism of the o-nitrobenzyl group. 
 
From a synthetic standpoint, designing a caged compound is rather clear-cut and 
seemingly uncomplicated.  One must simply identify an essential functional group 
required for biological activity and covalently modify that group with a photolyzing 
moiety.  This strategy has been successfully utilized to provide an array of caged 
biomolecules, ranging from small molecule effectors29, 30, 33, 38, 39 to biological 
macromolecules, including nucleic acids28, 31, 32, 40, 41 and amino acids, of which the latter 
will be addressed in greater detail. 
As stated previously, there have been several methods employed for the direct 




reported.  The differing methodologies will be introduced in further sections.  For the 
application and delivery of caged UAAs, site-specifically at the genetic level, there have 
been several successful attempts utilizing the caged versions of tyrosine20, 22, 42-44, 
cysteine19, 22, serine25, aspartic acid45-47, and lysine48.  For each of these amino acids the 
direct caging of the side chain resulted in the inhibition of the protein’s biological 
activity.  Subsequent decaging events lead to the release of the native amino acid, 
restoring the proteins function.   
The first genetically encoded caged amino acid was o-nitrobenzyl cysteine 
(ONBC, 1-7)19.  In a proof of principle experiment an essential active-site cysteine 
residue was substituted with ONBC on the human proaprotic protein caspase 3.  This 
protein is a member of the cysteine-aspartic acid protease family, which undergoes 
proteolitic activation from an inactive proenzyme to its active conformation.  When 
caspase 3 is activated it initiates cysteine mediated protease activity in apoptotic events49.  
The presence of ONBC in the caspase active site inhibited the enzyme’s ability to act as a 
protease, blocking in vitro cleavage events.  Photolysis resulted in the cleavage of the 
benzylic carbon-thiol bond and the release of the nitrosaldehyde, reestablishing nearly 40 
% of the enzyme activity.  This work outlined the possibility of spatiotemporal control 
for cellular processes that involve essential cysteine residues.  In this manner, a portion of 
the research performed for this dissertation will take advantage of this technology, 
directly applying the ability to decage a specific cysteine residue involved in protein-
small molecule interactions. 
More extensive work has been performed with the encoded caged amino acid o-




β-galactosidase (β-gal), an enzyme responsible for the hydrolysis of β-galactosides to 
monosaccharides50-52.  Following irradiation, and subsequent loss of the protecting group; 
nearly 70 % of the native activity was restored20.  In more recent studies the exploits of 
ONBY has been used to control polymerase activity setting the stage for temporal control 
over DNA replication44.  DNA polymerase is one of the key enzymes that catalyze the 
addition of deoxyribonucleotides to the 3’ end of a newly forming strand.  In an essential 
spatial arrangement, during the loading of a sequential nucleotide in the extension 
process, a vital tyrosine residue helps position the template-primer pair into the active 
site, enabling the DNA template to line up with the incoming nucleotide53.  Mutational 
studies of this residue indicate polymerase loss of function54.  Once again, the 
introduction of a caged tyrosine at a critically important tyrosine residue inhibited the 
enzyme’s native function.  While this residue is not mechanistically important, its 
conformational position is vital and the caging group is thought to block the access of a 
free nucleotide into the correct positioning for DNA strand extension.  Light induced 
decaging of polymerase, followed by polymerase chain reaction (PCR) with the caged 
enzyme, revealed that DNA amplification process could indeed be photo-activated.  
Caged enzyme that was not subjected to irradiation yielded no PCR product.  A wide-
range of other enzymatic activities have been reported with several caged derivatives of 
amino acids.  This approach still remains a small subset of biological research but is 
steadily moving toward the forefront of the chemical biology arena.       
The ability to control biological function with light is an extremely seductive 
approach.  There are many active biomolecules that have essential functional groups, all 




group.  The constraint here being that only one specific residue is required for its 
particular activity.  The approach is not well suited for interactions that occur over large 
molecular surfaces, including many protein-protein and nucleic acid-protein interactions.  
One of the more clever uses in this work is the attempt to mask amino acids that have 
only slight modifications, changing their electronic properties, but are still recognized by 
their endogenous aminoacyl-tRNA synthetases.  These UAAs will be termed near-
natural amino acids. 
1.2 Near-natural amino acids 
 As the term unnatural amino acid could fittingly be applied to the molecules being 
discussed in this section, it is appropriate to augment their label for distinct reasons.  It is 
true that these amino acids are non-natural; however, they are only slight variants of their 
native structures.  Subtle perturbations allow for the alteration of electronic properties, 
which can help elucidate biological activity with a means that could not be achieved 
through other methods.  The concern with near natural amino acids (NAA) is that they 
are recognized by the endogenous aminoacyl-tRNA synthetase machinery that naturally 
incorporates the non-modified amino acid.  This creates toxic effects when a NAA is 
introduced to cells, as the NAA will be integrated to all cellular protein at its respective 
native amino acid position.  
 
1.2.1 Fluorinated analogues of histidine and tyrosine 
 Histidine residues have the only side chain pKa (~6.5) that is near physiological 
pH.  Because of this, the imidazole group has the ability to act as a general acid/base 
catalyst for enzymatic activity.  The substitution of one hydrogen atom of the imidazole 




acidity55 (Figure 1-3).  Histidine has long been thought to play a role in acid/base 
catalysis in the mechanism of RNA hydrolysis by RNAse56.  The NAA 4-fluorohistidine 
(1-19) was substituted for the active site histidine in RNAse A and used to probe this 
catalytic reaction57.  As the mutant exhibited nearly the same catalytic rate (kcat) of the 
wild-type, its optimal pH was lowered, corresponding to the decrease in pKa of the active 
site fluorohistidine.  This data provides overwhelming support to the proposed 
mechanism of this enzyme and the implication that histidine does indeed act as a general 
acid/base catalyst.  This supporting information would not be obtainable by any other 
means as the direct fluorination of a histidine, posttranslationally, is experimentally 
impossible.   
 
Figure 1-3.  Histidine (1-18) and its fluorinated analogues.  The pKas of the near-natural 
histidines decrease as shown for 4-fluorohistidine (1-19) and 2-fluorohistidine (1-20). 
 
Fluorinated tyrosines have also found their way into an extensive amount of 
research involved in probing protein structure and function.  Some of the advantages of 
developing fluorinated proteins are the ability to directly investigate protein folding by 
19F NMR58-61, as well as introducing altered electronic properties resulting in lower pKa 
values of the phenolic proton62-64.  As demonstrated in Figure 1-4, the pKa of a 
tetrafluorinated derivative (2,3,5,6-tetrafluorotyrosine, 1-25) decreases the pKa of native 




approaches that of a carboxylic acid.  In a manner similar to that of fluorohistidine, the 
fluorinated tyrosines can act as powerful probes in the investigation of tyrosine active 
sites.  Indeed, this was performed with insulin receptor tyrosine kinase where direct 
control over the pKa of the substrate tyrosine (via fluorinated derivatives) exposed that a 
neutral tyrosine was essential for enzyme activity65.   
 
Figure 1-4.  Tyrosine (1-21) and examples of its fluorinated analogues.  The pKa of each 
derivative decreases as more fluorines are substituted on the ring.  
  
 For both of the mentioned NAAs there remains the complication of efficiently 
generating fluorinated proteins.  Synthetic routes have found their utility in the above 
examples66-69, but protein size becomes a concern, as larger proteins find synthetic yields 
are more difficult to obtain.  The direct inoculation of cell cultures with these NAAs 
proves toxic as they are recognized by endogenous translation machinery and they are 
inserted into all positions which would recognize either a histidine or a tyrosine.  This is 




substitution for hydrogen, of which the aminoacyl-tRNA synthetase cannot distinguish 
and recognizes as a substrate for the charging of tRNA.   
1.2.2 Selenocysteine 
 While there are potentially limitless possibilities for slight modifications of amino 
acids, one of the more intriguing analogues is selenocysteine.  This amino acid falls into a 
unique category as it is structurally similar to cysteine; however, it is a natural amino 
acid.  Site-specific encoding of this amino acid is technically difficult as its natural codon 
is UGA, a universal stop codon, followed by a sequence of mRNA (Selenocysteine 
Insertion Sequence, SECIS) that specifically recruits cellular machinery required for 
selenocysteine incorporation.  Without the specific SECIS sequence there is no insertion 
of the amino acid.  These represent obvious molecular biological constraints when 
designing mutational expression sequences.  The appeal of this particular residue is the 
selenol side chain which has a reduced pKa of 5.370.  Not only would direct control over 
insertion of this amino acid provide invaluable data about natural selenocysteine proteins, 
the reduced pKa and increased nucleophilicity of this side chain group make it an 
extremely attractive candidate for the evolution of new enzyme function as well as a 
handle for selective bioconjugation.  Synthetic71, 72 and chemical73 approaches have been 
utilized, but in each case there are definitive limitations with their own technical 
challenges.  No direct method exists for site-specific incorporation of NNAs into proteins 
of larger size, and at any desired position.                               
1.3 An expanding genetic code 
 There are several different techniques by which the generation of protein with 




synthetic stand point, utilizing solid-phase peptide synthesis.  This strategy is extremely 
effective for small peptides where the diversity of the sequence is unlimited.  For larger 
proteins this method becomes technically restricted as the efficiency and purification 
yields, following each successive amino acid addition, decreases substantially.  There is 
also the concern that a synthetic protein may not fold properly into its active 
conformation once it is introduced to biological conditions.  Straightforward chemical 
modification of amino acid side chains can alter functionality.  However, direct control 
over chemical events are often difficult to manage as proteins contain many of the same 
residues of interest along any one polymer.  This can lead to nonselective binding, or 
multiple modifications, skewing quantitative results.  More recently, expressed protein 
ligation and protein trans-splicing techniques combine the use of synthetic peptides, 
coupled with the expression of a truncated protein68.  Both of these methods were 
introduced by Muir, et al.66, 68 and are based on intein splicing mechanisms, which can 
ultimately fuse synthetic peptides to expressed protein.  As clever as this technique may 
be, the limitation of introducing an UAA is constrained by the size of the peptide being 
synthesized, resulting in recombinant protein that contains a mutation sequentially 
located near either termini of the protein.  This becomes a dilemma if the mutation of 
interest is desired near the center of a large protein.   
 There have been successful attempts at the expression of protein in the presence 
of chemically misacylated tRNAs, in vitro74 and in vivo75.  This requires the chemical 
modification, and “false” charging, of a tRNA that recognizes a specific codon.  For the 
in vitro studies this was done using a nonsense or frameshift suppressor tRNA and in vivo 




translational mechanism, and both require the chemical additions of mis-acylated tRNAs 
which limits the production of protein as the tRNA cannot be reacylated once it has been 
utilized.  
 A model system would be able to generate unnatural proteins with site-specificity 
at the genetic level without the need for multiple injections of chemically altered tRNAs.  
This would allow for the expression of protein containing UAAs at any position, and at 
sufficient yields, by which isolation and purification methods could be applied.  These 
techniques have been developed and implemented through standard mutagenesis 
procedures, in order to evolve a unique aminoacyl-tRNA sythentase (aaRS)/suppressor 
tRNA pair, specific for the amber codon UAG.  This system has been termed “an 






Figure 1-5.  A general method for the in vivo expression of proteins with an aminoacyl-tRNA 
sythentase (aaRS)/suppressor tRNA pair, specific for the amber codon UAG.  This orthogonal 
pair works to suppress the amber codon and express full length protein in the presence of 
unnatural amino acids.          
 
1.3.1 Amber suppression 
 One of the key components of this new technology is the ability of a tRNA 
mutant to recognize and suppress the amber stop codon, UAG.  This codon is the least 
utilized terminator in both E. coli and yeast.  Initial attempts were performed in E. coli 




an aaRS that would recognize an UAA as a substrate and none of the other twenty 
naturally occurring amino acids.  In turn, the charged tRNA specific for a UAG codon 
would translate and suppress the amber position.  Preliminary evolution of these tandem 
components were performed on existing pairs selected from E. coli76, 77, and yeast78 with 
some impediment.  Although orthogonal translational partners were generated, these 
initial pairs found complications with specificity, charging and suppressing the UAG 
codon with natural amino acids. 
 It was determined that an existing pair from archael bacteria provided the perfect 
host by which to evolve orthogonal pairs for the use in E. coli.  This was due to the fact 
that no cross-reactions would occur to any significant degree because archael tRNAs will 
not act as a substrate for an E. coli aaRS79.  The first truly functional orthogonal 
tRNA/aaRS pair to be used in E. coli was derived from the tyrosyl pair from 
Methanococcus jannaschii80.  One of the defining characteristics of this tyrosine tRNA 
(Mj tRNATyr) was that its sequence had differing recognition elements in comparison 
with E. coli tRNATyr.  The first base pairing in the acceptor stem is varied, where E. coli 
contains a G-C pairing and M. jannaschii contains the reverse, C-G pairing (Figure 1-6).  
Another point of interest is the fact that the M. jannaschii tyrosyl-tRNA synthetase (Mj 
TyrRS) contains a minimal binding domain with the Mj tRNATyr anticodon loop making 
it possible to mutate this sequence of the tRNA without a considerable loss of affinity by 
the synthetase81.  Indeed, mutation of the anticodon loop was attained altering the codon 
recognition sequence from UAC to UAG (Mj tRNATyrGUA  Mj tRNATyrCUA) whereby 
suppression of the amber codon was observed using the Mj tRNATyrCUA/Mj TyrRS pair in 





Figure 1-6.  Sequence homology of tRNATyr from both E. coli and M. jannaschii as well as the 
mutant Mj tRNATyrCUA.  Mutated nucleotides are shown in red where the anticodon region is in 
purple.    
 
 The Mj tRNATyrCUA was further evolved to reduce endogenous synthetase 
recognition of the tRNA.  A mutant suppressor tRNA library was designed based around 
eleven nucleotides which do not have direct interactions with the Mj TyrRS82.  Several 




fully optimal, completely orthogonal, Mj tRNATyrCUA that was recognized efficiently by 
Mj TyrRS to suppress the amber codon (Figure 1-6).  Having a system in place lead to the 
evolution of the Mj TyrRS to recognize specific UAAs, and charge them to the cognate 
Mj tRNATyrCUA. 
1.3.2 Synthetase recognition of unnatural amino acids 
 The substrate recognition of Mj TyrRS was evolved to specifically recognize, and 
charge its tRNA partner, with an UAA and none of the natural amino acids.  To 
accomplish this, mutant libraries were generated with random mutations introduced 
throughout the tyrosine binding site.  These sites were based on crystal structures of the 
wild-type synthetase.  Successive rounds of positive and negative selections were 
performed with the library of mutant synthetases in the presence of a desired UAA to 
evolve the most efficient translation pair.   
 Several different selection techniques have been applied for this system where the 
first general approach in E. coli will be discussed here (Scheme 1-2).  This scheme was 
applied to the evolution of Mj TyrRS to recognize, and selectively charge Mj tRNATyrCUA 
with O-methyl-L-tyrosine (OMe-Tyr)80.  The positive selection was based on an 
expression plasmid containing a chloramphenicol acetyl transferase (CAT) gene that 
included an internal stop codon.  When the library was expressed in the presence of this 
plasmid, only the mutated synthetases that recognize OMe-Tyr suppressed the amber 
CAT gene and survived in the presence of chloramphenicol.  Those library plasmids 
which survived the positive round were then transformed into a negative selection strain 




 Barnase contains ribonuclease activity, which is toxic to cells when expressed in 
the absence of an inhibitor83.  The key to this selection round is that selective pressure is 
performed in the absence of OMe-Tyr.  This step is imperative for removing mutant 
synthetases which are not orthogonal in E. coli and suppress the amber position with an 
endogenous amino acid.  When suppression occurs, the barnase activity is initiated and 
cell death occurs, ultimately eradicating synthetases which can still recognize native 
amino acid as a substrate.  This round provides cells, which house library plasmids 
encoding for only orthogonal or nonfunctional aaRS.  These two selections are performed 
multiple times, leading to the evolution of a mutant synthetase, which specifically 






Scheme 1-2.  General scheme for the positive/negative selections for the evolution of tRNA 





A similar approach was later developed which utilized a green fluorescent protein 
expression (GFPuv) driven by a T7 promoter that controlled expression of a T7 
polymerase.  The polymerase gene contains an amber codon which is dependent upon 
suppression for full-length polymerase activity84.  If the amber position in the polymerase 
gene is not suppressed there is no subsequent transcription of the GFP gene.  This 
positive selection also maintained the amber-CAT gene, as mentioned above.  When this 
selection was performed in the presence of UAA, suppression of the amber codon in the 
T7 polymerase gene afforded full length T7-polymerase, and in turn, the expression of 
GFPuv.  Survival was also dependent upon the suppression of the CAT gene, and growth 
in the presence of chloramphenicol.  An advantage to this system was the selective 
pressure was dependent on two separate events, both of which were contained in the 
same plasmid.  There was also a very clear phenotype, making sorting of fluorescent cells 
particularly efficient.  The plasmids from cells which contained this phenotype were then 
introduced to the negative selection round, as described above.  This alternative approach 
to the selection method is mention here due to its direct utilization in the work presented 
within.         
1.3.3 Reach of an expanding genetic code 
 Since the development of this system in E. coli, unnatural proteins have seen a 
surge in popularity throughout biological studies.  This is due to the fact that UAAs can 
now be introduced site-specifically at any position with standard molecular mutagenesis 
techniques.  Success in E. coli has lead to the direct development of this system in yeast 




 Although the eukaryotic transcription/translational machinery differs from that of 
E. coli, orthogonal pairs of tRNA/aaRS have been generated.  In selection schemes that 
approach the evolution of orthogonal pairs in similar fashion to those in the above 
mentioned methodology, tRNA/aaRS pairs from E. coli have been imported to yeast 
which act as the translational components for suppression.  Amber suppression in the 
yeast selections drive GAL4-responsive his3, ura3, and lacZ reporters85 where the 
negative rounds are based on the toxic effects of an amber uracil marker which converts 
5-fluoroorotic acid to its toxic product.  The details of this selection process will not be 
outlined in great detail, as this work did not directly apply this selection process; 
however, an evolved synthetase using this system was utilized for the incorporation of a 
caged cysteine. 
 In mammalian cells several different pairs have been generated which have been 
imported from bacteria86, 87.  These have seen the specific incorporation of UAAs 
including 5-hydroxytryptophan.  The fact that this selection process can extend into 
higher species highlights its practical nature and potential for highly specific protein 
studies using UAAs.  Not only does it possess the ability to probe protein function, it may 
also find its value in the newly emerging field of synthetic biology where its direct 
application could aid in the development of novel proteins with unprecedented function.              
1.4 Specific aims 
 This work is intended to expand an already impressive molecular toolbox for the 
exploration of protein structure and function.  It spans many fields of study, specifically 
those of chemistry and biology, utilizing various molecular biological techniques.  With 




undeveloped, seems limitless.  The focus here is the development of new tools, where 
each specific case, will be applied to a proof-of-principle system to illustrate its 
usefulness for further applications.   
 Exploitation of previously evolved tRNA/aaRS pairs will be applied to studies 
which recognize close analogues of their reported cognate amino acids.  This will serve 
to incorporate isotopic pairs of a crosslinking amino acid for fingerprinting studies via 
mass spectral analysis.  Another system will be used to explore the use of spatiotemporal 
control with a caged amino acid, where light activated fluorescent labeling of a protein 
will be addressed.  Work in both of these examples extends the applications of existent 
translational partners. 
 The ability to increase the number of UAAs available for protein studies is one of 
the appeals of such a general selection method.  It creates an unlimited number of 
potential candidates for new orthogonal pairings for the suppression of the amber codon.  
As discussed above, the near-natural analogues of amino acids are not suitable candidates 
for this system as they are recognized by endogenous synthetases.  This work applies 
directly the selection scheme in E. coli for the evolution of a new tRNA/aaRS pair which 
specifically recognizes the caged version of near-natural fluorinated tyrosine derivatives.  
This work takes advantage of UAA technology to mask near-natural amino acids for their 









Chapter 2: Mass spectral fingerprinting via the genetic 
encoding of an isotopically labeled photoaffinity probe 
2.1 Introduction 
  Many methods have been developed to identify, map, and potentially inhibit 
protein-protein interactions.  Classic analysis has been performed through techniques 
such as co-immunoprecipitation88, where protein associations are strong enough to 
survive cell lysis techniques and can be captured by affinity purification assays.  This 
technique is rather powerful but can miss transient protein interactions, which are 
more difficult to discern using in vitro methods.  Alternatively, in vivo techniques 
such as the yeast two-hybrid assay89, 90, protein fragment complementation91-93, or 
fluorescence resonance energy transfer (FRET)94 can be employed, which are not only 
sensitive, but can survey protein-protein interactions in the physiological environment 
of the cell.  A major limitation of these approaches, however, is that they require 
candidates to be expressed as fusion partners, and therefore judged as pairs.  This can 
prevent the direct identification of unknown interaction networks that are so often 
part of large protein complexes and signalling pathways. 
While, the previously described techniques help identify potential binding 
partners, they provide little, if any, information about the molecular detail of the 
interaction.  Chemical crosslinking, paired with mass spectral analysis can identify 
specific interfacing amino acid residues responsible in the molecular binding events at 
protein interfaces95-97.  What would normally be transient interactions can be seized by 
covalent attachment of reactive compounds.  These covalently captured proteins can then 




spectrometry to determine peptide fragments that contain crosslinked product.  As 
straightforward as this technique may appear, there are limitations as to the specificity of 
a desired crosslink.  Typically, the protein and crosslinking agent are mixed together in 
vitro and then analyzed for crosslinking activity.  Many agents are specific for only one 
type of functional group, where there are bound to be multiple positions for a group along 
any one peptide chain.  This creates difficulty when interpreting the crosslinked complex 
due to either the unknown position of the crosslink, or multiple crosslinking within the 
same complex.    
 Benzophenone (2-1) photochemistry has long been used to probe and identify 
non-covalent interactions in living systems98, dating back nearly 35 years to its first 
application in biological context99.  This probe has three distinct advantages.  The first is 
the wavelength by which the manipulation of this compound is performed.  It is activated 
with ambient light at a wavelength of 350-360 nm.  This relatively low energy ultraviolet 
radiation is not damaging to protein or DNA.  This is an extremely important point for 
employing this compound in in vivo studies.  Secondly, benzophenone reacts 
preferentially with C-H bonds within 4 Ǻ, even when water is used as a solvent.  This 
interaction is favorable for crosslinking biomacromolecules, particularly amino acids at 
side chain carbons.  The last advantage is the stability of the benzophenone.  Once 
activated it readily relaxes to the ground state configuration if an H-donor is not found.  
This is advantageous for probing in vivo because if a connection is not made, the 
relaxation and excitation can go through cycles until the proper H-donor and geometry of 





Scheme 2-1.  Photochemical pathway of the benzophenone radical mechanism.  When activated, 
one electron in the benzophenone photophore is promoted from a non-bonding sp2-type orbital on 
the oxygen to an antibonding π* orbital of the carbonyl group. 
 
  The diradical triplet state (2-2) contains an electron deficient oxygen which 
acts as an electrophile to react with adjacent C-H sigma bonds resulting in the 
abstraction of hydrogen from the carbon (Scheme 2-1).  The resulting radicals readily 
recombine to form a new C-C bond, affording a benzpinacol-type compound (2-3).  
When the excited oxygen is in spatial orientation with an amine, or other comparable 
heteroatoms, the reaction may occur through an electron transfer resulting in a 
hydrogen abstraction from an adjacent alkyl group and a consequent 1,2-radical shift.   
 Early successes with photoaffinity labeling clearly outlined its potential in 
biological applications100, 101; however, these first attempts at modifying peptides with 
photolabile probes were dependent upon hetero-bifunctional agents.  These probes 
consisted of both a chemically reactive group as well as a photochemical handle.  The 
photoactive group could only be introduced at a chemically comparative peptide site, 
which could potentially limit the functionality of the protein, or block ligand binding 
sites.  Another complication, as stated previously, was dependent on how many 
functionally reactive sites were present along one peptide chain.  A bifuntional 




the compound is introduced to the system.  There are typically many functional sites 
along a peptide by which the agent can react eliminating specificity control over the 
molecule.     
  
Figure 2-1.   p-Benzoylphenylalanine 
 
  To eliminate site-specific reactivity a photoreactive amino acid, p-
benzoylphenylalanine (pBpa), was synthesized that could be easily incorporated into 
proteins through standard solid-phase techniques102 (Figure 2-1).  This arylketone 
derivative of phenylalanine displayed the stability and the remarkable selectivity of 
benzophenone when used for crosslinking.  Succesful sythentic mutation with pBpa 
resulted in crosslinking events at a seventy percent yield102. 
  As this method proved to be a powerful adaptation of the benzophenone 
functionality, it too had its limitations.  The ability to incorporate this unnatural 
amino acid through solid-phase technology is hindered by the size of the peptide by 
which it is to be introduced.  Short peptides are typically simple to synthesize with 
relatively high yields (more than ever with the advent of automated microwave 
synthetic synthesizers), but solid-phase synthesis of larger protein becomes 
exhausting.  Recently, pBpa has been site-specifically incorporated into proteins in E. 
coli15, yeast85, and mammalian cells103.  Using an orthogonal tRNA/aaRS pair that 
was constructed to insert pBpa into proteins at the amber codon, TAG.  Not only does 




specific incorporation of pBpa into any size protein of interest.  
  As mass spectrometric analysis is increasingly becoming the standard practice 
to map protein-protein interaction surfaces of chemically cross-linked proteins, a 
major concern presents itself when trying to assign the cross-linked fragment of an 
unknown protein to a peak in the spectrum.  This is problematic as the complexity of 
fragments that can result from enzymatically treated complexes is not trivial.  
Different peptide fragments can have the same nominal mass depending on their 
sequence.  This is further exemplified by missed cleavages during the enzymatic 
digestion which generates peptides of unpredicted masses. 
  This chapter will outline a means of simplifying this analysis during the use of 
unnatural amino acid mutagenesis, an isotopically labelled analogue, [D11]-pBpa, was 
synthesized and used as an encoded label to identify peptide fragments that have been 
site-specifically cross-linked and analyzed via mass spectral techniques104.      
 
 
Figure 2-2.  General application of labeled pBpa for isotopic fingerprinting.  When mixed 
isotopes of pBpa are introduced to protein, the introduction of an M, M +11 fingerprinting 
doublet will be observed during mass spectral analysis.  This signature doublet will allow for 





2.2  Experimental 
2.2.1 Materials 
 [D8]-Toluene and [D5]-benzoylchloride were purchased from Sigma.  All 
enzymes were purchased from New England Biolabs.  Sequencing was performed at the 
University of Michigan sequencing facility.  All other reagents were purchased 
commercially and used without further purification.  The plasmid pSUP-pBpa was 
supplied by Dr. Peter Schultz (The Scripps Institute, La Jolla, CA).   
2.2.2 General Methods 
 The antibiotics employed were chloramphenicol (35 μg mL-1) and ampicillin (100 
µg mL-1).  PCR reactions were performed with Taq DNA polymerase under the following 
conditions for 30 cycles:  30 s at 95 °oC, 30 s at a calculated annealing temperature (5° 
below the lowest oligo Tm), and extension time of 1 min/Kb at 72 °C.  DNA isolations 
were performed using QIAGEN mini-prep kits according to manufacturer’s protocols.  
Ligations were performed using T4 ligase under standard conditions.  All transformations 
were performed into GeneHogs (Invitrogen) electro-competent cells using ~100 ng of 
DNA transformed into 100 µL of cells.  pBpa was dissolved in water with 0.5 M NaOH 
added dropwise until fully dissolved at room temperature, prior to being added to 
expression media.  UV irradiation (360 nm) was performed with a hand-held 100W Blak 
Ray lamp used at a distance of 5 cm, at 4 oC, for 30 min.  Purification of GST was 
performed using Probond Purification resin (Invitrogen) according to the manufacturer’s 
protocol for native isolation.  Denaturing discontinuous sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) gels (12 % acrylamide resolving and 




procedures, performed at 200 V for 65 min.  SDS-PAGE gels were stained with 
Coomassie Brilliant Blue.  Matrix-Assisted Laser Desorption/Ionization-Time of Flight 
(MALDI) samples were prepared with external standards:  insulin (bovine), 25 pmol μL-1 
in 0.1% TFA; insulin oxidized B, 25 pmol μL-1 in 0.1% (v/v) TFA.  Sinapinic acid was 
used for the matrix at a concentration of 10 mg mL-1 in 50% (v/v) acetonitrile/0.05% 
(v/v) TFA.  Spotting solutions were 4:1:1:2 μL (tryptic protein: insulin ox B: insulin: 
matrix) of which 2 μL was spotted on the MALDI plate, in triplicate.  MALDI spectra 
were recorded on an Axima-CFR spectrometer (Shimadzu) operating in reflectron mode 
at 90% maximum intensity, optimized for m/z 3500.  All spectra were the sum of 500 
laser shots per spectra.  
2.2.3 Synthesis of [D11]-p-benzoylphenylalanine 
 The precursor bromomethylbenzophenone (2-4), was synthesized as previously 
reported105, and used to assemble the amino acid as follows (Scheme 2-2). 
Diethylacetamidomalonate (614 mg, 2.83 mmol) was added to a stirring solution of 
sodium ethoxide (385 mg, 5.66 mmol) in ethanol (10 mL).  2-4 (810 mg, 2.83 mmol) was 
dissolved in ethanol (15 mL) and added dropwise over the course of ten minutes.  The 
reaction mixture was brought to reflux for 24 hours.  Upon cooling, water (20 mL) and 
ether (20 mL) were added and the organic layer was separated.  This was washed 
successively with 1% (w/v) NaHCO3, brine, and then dried over MgSO4 and concentrated 
under vacuum.  Deprotection was performed by the addition of 6 M HCl (40 mL) and 
then brought to reflux for 24 hours.  Upon cooling, the reaction mixture was dried under 
vacuum.  Recrystallization with water afforded the desired amino acid as light yellow 




133.44, 131.26, 130.59, 130.35, 129.07, 54.72, 36.46.  HRMS (ESI) for C16D11O3NH4 
calculated 280.1913, found 280.1928.   
2.2.4 Plasmid construction and protein expression 
 The gene encoding glutathione-S-transferase (GST) was amplified from pGEX-
T4-1 (GE Healthcare) using primers (FWD) 5’- CTA GGA TCC CCT ATA CTA GGT 
TAT TGG -3’ and (REV) 5’- CCA GTC GAC GCC TCT AGA AAC CAG ATC CGA 
TTT -3’.  The product was then digested with BamHI and SalI and cloned into the BglII 
and SalI sites of pBAD-mycHisA (Invitrogen) resulting in the addition of an N-terminal 
MDPSSR leader peptide and a C-terminal hexa-histidine tag.  Mutation of the F51 codon 
to TAG (mutation underlined, note: position 51 is in reference to the WT position.  In the 
gene sequence used for these expressions the mutation resides at position F57 due to the 
introduction of the leader peptide) was performed using standard Quickchange PCR with 
primers (FWD) 5’-TTG GGT TTG GAG TAG CCC AAT CTT CCT -3’ and (REV) 5’-
AGG AAG ATT GGG CTA CTC CAA ACC CAA -3’.  These mutated plasmids were 
then transformed along with the pSUP-pBpa plasmid into E. coli.  Transformants 
containing pBAD-GST51TAG, and pSUP-pBpa were inoculated in LB medium 
containing ampicillin and chloramphenicol and grown in the presence of 1 mM pBpa 
(Bachem), or 1 mM pBpa[D11], or 0.5 mM pBpa/0.5 mM pBpa[D11] and grown to OD600 
= 0.8.  The cultures were induced with 0.2 % (w/v) arabinose and allowed to express for 
5 hr.  Purified protein was subjected to crosslinking at time intervals of 15 min and 30 




2.2.5 Tryptic analysis 
 Gel bands to be used for in gel tryptic digests were cut into small cubes and 
destained twice with 100 mM NH4HCO3 in 50% MeCN (200 μL) for 45 min at 37 °C.  
The gel pieces were dried by Speedvac, and then 10 mM DTT in 100 mM NH4HCO3 
(100 μL) was added for 15 min at 37 °C.  The supernatant was removed and a solution of 
55 mM iodoacetamide in 100 mM NH4HCO3 (100 μL) was added for 30 min at 37 °C, in 
the dark.  The supernatant was discarded and the gel cubes were washed 3 times with 25 
mM NH4HCO3 (200 μL) for 15 min at room temp.  The gel pieces were dried by speed 
vac, and then trypsin buffer (12.5 ng/μL trypsin in 50 mM NH4HCO3, 60 μL) was added 
and incubated for 1 hr at 4 °C.  The supernatant was removed and the gel pieces were 
covered with 40% (v/v) MeCN in 40 mM NH4HCO3 (50 μL) then incubated for 18 hr at 
37 °C.  The supernatant was removed and saved and then 0.1% TFA (50 μL) was added 
to the gel pieces for 1 hr at 37 °C.  This supernatant was combined with the previously 
saved supernatant and dried by speed vac.  The tryptic fragments were resuspended in 
50% (v/v) MeCN/0.05% (v/v) TFA (15 μL), ready for mass spectrometry analysis. 
2.3 Results and Discussion 
2.3.1 Synthesis and substrate recognition of isotopically labeled p-
benzoylphenylalanine  
 As a means of simplifying mass spectral analysis during the use of unnatural 
amino acid mutagenesis, an isotopically labelled analogue of pBpa, [D11]-pBpa, was 
synthesized and use as an encoded label to identify peptide fragments that have been site-
specifically cross-linked.  The synthesis of the deuterated amino acid began with a 
Friedel-Crafts acylation of [D8]-toluene with [D5]-benzoylchloride (Scheme 2-2).  The 




acetamidomalonate to give the protected amino acid.  The resulting intermediate was de-
protected by acid hydrolysis to afford the amino acid in four steps.  This synthesis is non-
stereoselective and yields a racemic mixture, of which only L-[D11]-pBpa is incorporated 
into protein.  This approach afforded labeled amino acid on the gram scale, providing 
sufficient material for many protein expression studies. 
 
Scheme 2-2.  Synthetic scheme for the synthesis of [D11]-p-benzoylphenylalanine.  a) [D8]-
Toluene, [D5]-benzoyl chloride, AlCl3  ; b) NBS, AIBN, CCl4, reflux overnight; c) 
Diethylacetamidomalonate NaOEt/EtOH, reflux, 24h  d) 6N HCl reflux, 24h.  
 
 To determine if the cross-linked peptide fragments were easily observable with 
mass spectrometry, [D11]-pBpa was incorporated into GST.  In its native form GST is 
dimeric, and has been shown to nonspecifically106 and specifically15 cross-link.  GST was 
expressed containing a pBpa mutation in place of phenylalanine 57 (F57), a position 
located in the dimeric interaction surface107 (Figure 2-3).  The residue F57 refers to the 
mutational position following the introduction of a leader peptide during construction of 
the plasmid for this study.   The position of the mutation is located at F51 on the wild-
type protein.  It was assumed that with such a small structural change to pBpa, [D11]-
pBpa would also act as a substrate, and be accepted by the previously evolved aminoacyl-




endogenous aaRS, [D11]-pBpa acts as an isoteric match for substrate recognition of the 
previously evolved tRNA/aaSR pair.  Therefore the amino acid could be inserted into 
proteins using the previously described machinery.    
 
Figure 2-3.   Crystal structure of the homodimer of Schistosoma japonicum GST.  F51, which sits 
at the dimeric interface on both monomers, is highlighted in orange.  PDB entry 1y6e.   
 
Protein expression media was supplemented with either unlabeled [D0]-pBpa, 
labelled [D11]-pBpa, or a 1:1 mixture of each of the isotopic variants. Following protein 
isolation, solutions of protein containing the unnatural amino acid were irradiated with 
360 nm light to instigate cross-linking.  The wild-type protein was also irradiated as a 
negative control.  As can be seen in Figure 2-4, isolated GST containing unnatural amino 
acid was irreversibly captured as a covalent dimer.  No reaction was observed for the WT 




is indeed a substrate for the previously evolved aminoacyl-tRNA synthetase and that it 
also exhibits identical photoreactivity. 
 
Figure 2-4.  Coomassie stained SDS-PAGE gel of GST protein isolation following irradiation at 
360 nm for the indicated time.   
 
2.3.2  Mass spectral analysis of crosslinked peptides  
The protein bands corresponding to the monomeric and cross-linked proteins were 
excised from the SDS-PAGE gel and digested with trypsin.  The resulting peptides were 
analyzed by MALDI-TOF mass spectrometry.  The residue of interest, F57, was mutated 
to TAG and resides on the predicted GST fragment 51-
FELGLEpBpaPNLPYYIDGDVK-69 with m/z = 2333.2.  Upon inspection of the mass 
spectrum no peak was observed corresponding to this mass.  However, there is a larger 
peak at m/z = 2460.5 that could possibly be assigned to a mis-cleaved fragment 
containing an extra lysine residue, 50-KFELGLEpBpaPNLPYYIDGDVK-69.  Indeed, 
inspection of the tryptic fragments of protein produced using [D11]-pBpa displayed a M 
+11 peak at m/z = 2471.4, and a 1:1 mixture of the two variants displayed the 




this strategy, the spectra was searched for the corresponding cross-linked protein at the M 
and M +11 signature fingerprint quickly identifying peaks at 3028.8 and 3039.5, 
respectively (Figure 2-5).  The observed mass difference of 695.6 between the original 
peptide (2333.2) and the measured mass of 3028.8 matches the specific capture of GST 
residues 137-MFDER-141 to the original peptide. 
 
Figure 2-5.  The MALDI-TOF spectra of trypsinized monomeric and cross-linked GST, isolated 
from the SDS-PAGE bands as shown in Figure 2-3. Each spectrum shows a zoom of the area 
encompassing the assigned peak, where the remaining spectra are identical. The assigned peaks 
for the peptide shown differ by 11 Da, depending on the unnatural amino acid used. 
 
    
Inspection of the X-ray crystal structure of the GST dimer interface shows that 
indeed, this fragment is within 4 Å of the mutated residue, on the opposing monomer 
(Figure 2-6).  No other tryptic fragments, isolated from these gel bands, displayed the M 
and M +11 signature peaks, therefore these were confident assignments of fragments 
captured by photo-crosslinking.  Intriguingly, non-crosslinked peptide is not seen in these 




crosslinked.  Furthermore, there is no indication of intramolecular crosslinks within the 
GST monomer.  Thus, site-specific crosslinking using these unnatural amino acids can 
provide accurate MALDI-TOF data that is structurally relevant information, provided the 
mass peaks are assigned.   
 
Figure 2-6.  Structure of the GST dimer interface where the position of the mutated F51 is 
depicted in orange on the blue monomer.  The residues on the opposing monomer (137-MFDER-
141) are shown in grey, where M137 and F138 are within 4 Å of the crosslinking agent.  PDB 
entry ly6e.     
2.4 Conclusion 
 Isotopic encoding is a strategy that can be used in identifying protein interactions 
via crosslinking with the unnatural amino acid, pBpa.  The simplicity of this technique 
and the ease at which fragments of interest can be identified, significantly reduces the 
time for spectra analysis.  This isotopic fingerprint alleviates the need for multiple 
calculations that would previously have been needed to deduce the correct fragment.  




where the signature M and M +11 peaks are very clear.    Recently several groups have 
employed photo-crosslinking amino acids to capture unknown protein binding partners in 
vivo 108, 109.   Using a strategy such as the one described here it may now be possible to 
not only directly identify proteins via tandem mass spectrometry with rapid peak 
identification, but also determine the site of crosslink formation with single amino acid 
accuracy.  Large-scale proteomic projects that map protein complex connectivities may 
benefit from such an approach.   
The labelled [D11]-pBpa compound synthesized in this work has been requested 
for use in the lab of Dr. Alan Warren at the MRC laboratories in Cambridge, England.  
His group has successfully utilized the applications of this work to assign crosslinked 
peptides in previously unknown protein-protein interactions in the eukaryotic ribosome 





Chapter 3: Photochemical control of fluorescent binding to a 
genetically encoded sequence tag with o-nitrobenzyl cysteine 
3.1 Introduction 
 The discovery and evolution of green fluorescent proteins (GFP) has 
revolutionized the study of biology110-113.  This protein can be engineered as a fusion tag 
to fluorescently label a protein of interest in vivo.  The extensive array of proteins 
contains a wonderful palette of colors that allows multiple proteins to be tagged with 
different colors within the same cell.  More recently, this collection of proteins has been 
expanded to include those that change optical properties upon irradiation resulting in 
photo-activatable GFPs (PA-GFP)114.  These modified analogs of the wild-type protein 
exhibit a significant increase in fluorescence when stimulated to their active 
conformation114.  Other photo-activatable proteins, similar to GFPs, have also been 
reported.  A coral fluorescent protein has been modified to yield photo-activatable 
proteins capable of switching from red to green wavelengths (Kaede)115 as well as 
exhibiting fluorescence recovery after photobleaching (FRAP) demonstrating the ability 
to flip-flop between fluorescent signal  (Dronpa)116.  These light induced “switches” 
provide spatiotemporal control over protein fluorescence.  Provided an appropriate 
microscopy platform, one can track the movements of single protein molecules within a 
cell at sub-difraction resolution by photo-activation followed by fluorescence tracking65, 
117. 
 Of course, there are limitations to fluorescent proteins including brightness, rate 
of chromophore formation, and size (GFP contains 238 amino acids).  There is always the 




being studied.  It could disrupt a protein-protein interaction, or subcellular localization 
resulting in data that is not biologically relevant.  The rate of GFP formation is also an 
issue as it must complete several rounds of self-modification to generate fluorophores, 
taking up to hours to become fluorescent113.  Further, there are only two available colors 
of PA-GFPs currently available, limited to assays using only fluorescence spectrometry 
where the activation levels of PA-GFP are only reported to be a 100-fold difference in 
fluorescence compared to that of GFP114.  
 
Figure 3-1.  Chemical structures of FlAsH and ReAsH. 
 
 As an alternative, Tsien and co-workers introduced the biarsenical pro-fluorescent 
dyes 4,5-bis(1,3,2-dithioarsolan-2-yl)fluorescein and 4,5-bis(1,3,2-dithioarsolan-2-
yl)resorufin (FlAsH and ReAsH respectively) that specifically bind to, and are activated 
by the small amino acid tag sequence, CCPGCC118, 119 (Figure 3-1).  They were inspired 
by the fact that such binding events were responsible for the toxicity of arsenic 
compounds, as they covalently bind to cysteine pairs that are in close proximity to one 
another.  These toxic interactions are completely reversible by the introduction of small 
vicinal dithiols such as 1,2-ethanedithiol (EDT), which associate in a tighter binding-
complex than cellular dithiols120.  It was believed that a protein motif could be designed 




with EDT, in turn, allowing for a peptide binding domain specific for arsenical 
compounds, even in the presence of excess cellular dithiols.  This domain was designed 
with four cysteines at a spatial distance as to confer proper orientation of the two thiol-
arsenic interactions.  Cysteines placed at the i, i+1, i+4, and i+5 positions allowed for 
cooperative and entropically favorable binding119, allowing for the four thiol groups to 
react on one side of the helix in correct geometry with the arsenic ligand.  This small 
genetically encoded sequence (TC tag) is orthogonal to cellular proteins and can be 
labeled extremely selectively and efficiently in vivo.                 
The first successful fluorescent binding partner to the newly designed motif was 
FlAsH.  This nonfluorescent molecule, derived from fluorescein mercuric acetate, 
exchanges EDT for the tetracysteine motif generating a distinctly fluorescent protein-
bound complex118 (Figure 3-2), becoming more than 50 000 times more fluorescent.  It is 
thought that the fluorescein compound is not fluorescent when bound to EDT due to 
vibrational quenching or photo-induced electron transfer mechanisms.  Presumably the 
rigid conformation of the peptide-arsenical complex is too constrained to allow for 





Figure 3-2.  FlAsH labeling of tetracysteine motif on any protein of interest. 
 
The nominal size (~700 Da) of the TC-tag has shown less protein perturbation as 
compared to the relative size of the fluorescent fusion proteins121-123 and has been applied 
as a new approach to fluorescent resonance energy transfer (FRET) studies124, 125.  These 
short tags have also been shown to serve as useful probes of protein-protein interactions 
and protein conformational changes using distal Cys-Cys pairs126.  Whereas these dyes 
show advantages to GFP fusions, there is no mechanism for the spatiotemporal control of 
protein labeling, and therefore all proteins within the cell displaying the CCPGCC motif 
are labeled.  
 The tetracysteine sequence is critical for the function of these dyes and a single 
amino acid change causes a major decrease in fluorescence due to destabilization of the 
biarsenical complexes118.  This requirement was taken advantage of to extend a level of 
control to the labeling and fluorescence events by temporarily masking the cysteine 
residues in the TC-tag.  The genetically encoded unnatural amino acid o-nitrobenzyl 
cysteine (ONBC) can be site-specifically introduced into proteins in yeast cells in 




upon irradiation with UV light (365nm) (as detailed in Section 1.1.2) and therefore tag 
labeling and activation of fluorescence should only occur after irradiation (Figure 3-3).  
Due to the fast  association rate for these complexes (~310000 M-1s-1, fluorescence 
observed in seconds)118 photo-activation of fluorescence is rapid and therefore might 
serve as a supplement to PA-GFP.  In the case of precise light delivery, this might allow 
individual protein molecules to be selectively fluorescently labeled.   
This chapter will outline the use of photocaged cysteines as a means of blocking 
small molecule binding to a tetra-cysteine tag.  When FlAsH labeling is introduced in the 
presence of ONBC at a position in the tag, it will inhibit fluorescent labeling of the 
protein.  Once the protein is subjected to light irradiation, the cysteine is freed from the 
protecting group, thereby allowing for fluorescent labeling of the protein.  This light-
activated binding adds a level of spatiotemporal control to small molecule binding events 
to protein (see Figure 3-3).         
 
 
Figure 3-3.  Process of UV-induced activation of fluorescence.  A caged cysteine mutation in 
place of one of the cysteines in the TC-tag results in the inhibition of fluorescence.  Upon 






3.2.1  Materials 
 Reagents for the synthesis of FlAsH were purchased from Fisher.  All enzymes 
were purchased from New England Biolabs and Fermentas.  Sequencing was performed 
at the University of Michigan sequencing facility.  All other reagents were purchased 
commercially and used without further purification.  The plasmid pESC-PC-Cys was 
supplied by Dr. Peter Schultz (The Scripps Institute, La Jolla, CA).   
3.2.2 General Methods 
 FlAsH, 4,5-bis(1,3,2-dithiasolan-2-yl)fluorescein, was synthesized and 
characterized as previously described127.  The compound was dissolved in 100% DMSO 
to a final concentration of 10 mM for use.  PCR reactions were performed with Deep 
Vent DNA polymerase (NEB) under the following conditions for 30 cycles:  30 s at 95 
oC, 30 s at a calculated annealing temperature (- 5o of the lowest oligo Tm), and extension 
time of 1 min/Kb at 72 oC.  DNA isolations were performed using QIAGEN mini-prep 
kits according to manufacturer’s protocols.  .  Ligations were performed using T4 ligase 
under standard conditions.  All E. Coli transformations were performed into GeneHogs 
(Invitrogen) electro-competent cells using ~100 ng of DNA transformed into 100 μL of 
cells, and into InvScI chemical-competent cells (Invitrogen) for transformations into S. 
cerevisiae.  o-Nitrobenzyl cysteine was dissolved in water with 0.5 M NaOH added 
dropwise until fully dissolved at room temperature, prior to being added to expression 
media.  Expressions for the TAG mutants were carried out in yeast SD media containing 
2% glucose in the absence of uracil and tryptophan.  All protein concentrations 




held 100W Blak Ray lamp used at a distance of 5 cm, at 4 oC, for 30 min.  Purification of 
GST was performed using Probond Purification resin (Invitrogen) according to the 
manufacturer’s protocol for native isolation.  SDS-PAGE gels (12 % acrylamide 
resolving and 5% acrylamide stacking) and 1X Laemmli buffers were used following 
standard procedures, performed at 200 V for 65 min.  SDS-PAGE gels were stained with 
Coomassie Brilliant Blue.     
3.2.3 GST-tetracysteine tag plasmid construction 
 The gene encoding S. japonicum GST was amplified using the following primers 
to introduce the N-terminal tetracysteine tags containing TAG mutations (underlined) and 
a C-terminal 6 X His tag :  WT (no TAG mutations), FWD 5’-   ATA TTA AGC TTA 
CCA TGG GTT GTT GTC CAG GTT GCT GTT CCC CTA TAC TAG GTT ATT GG-
3’; C3TAG, FWD 5’-ATA TTA AGC TTA CCA TGG GTT AGT GTC CAG GTT GCT 
GTT CCC CTA TAC TAG GTT ATT GG-3’; C4TAG, FWD 5’-ATA TTA AGC TTA 
CCA TGG GTT GTT AGC CAG GTT GCT GTT CCC CTA TAC TAG GTT ATT GG-
3’; C7TAG, FWD 5’-ATA TTA AGC TTA CCA TGG GTT GTT GTC CAG GTT AGT 
GTT CCC CTA TAC TAG GTT ATT GG-3’; C8TAG, FWD 5’-ATA TTA AGC TTA 
CCA TGG GTT GTT GTC CAG GTT GCT AGT CCC CTA TAC TAG GTT ATT GG-
3’; REV (for all) 5’-AAA TCT AGA TCA ATG GTG ATG GTG ATG GTG GTC ACG 
ATG CGG CCG CTC G.  These were each cloned into the yeast expression vector 
pYES2 (Invitrogen, uracil marker) using the restriction enzymes HindIII and XbaI.  The 




3.2.4 Protein expression and isolation 
 GST-TC tag expressions were carried out in yeast SD media containing 2% 
glucose in the absence of uracil and tryptophan.  The cells were allowed to grow at 30 oC 
until OD600 = 1.8-2.0 then pelleted and washed with sterile water to remove remaining 
media containing glucose.  The cell pellets were resuspended in media containing 2% 
galactose (to the same OD600 to induce expression) in the absence of uracil and 
tryptophan, supplemented with 2 mM o-nitrobenzyl cysteine (WT carried out in only the 
absence of uracil with no unnatural amino acid added).  Expressions were performed at 
30 oC for 48 hrs in the dark.  Cells were lysed for protein purification using acid washed 
glass beads.  Cell pellets were resuspended in 1 mL of native binding buffer (Promega 
His-tagged resin protocol) where an equal volume of glass beads was added.  Shearing 
was done via vortex at high speed for 15 min.  Following cell lysis, cellular debris was 
pelleted at 15,000 rpm for 30 min.  The lysate was then purified using Promega Ni2+ resin 
following the manufacturer’s protocol.   
3.2.5 Fluorescence labeling studies 
For each isolated protein containing ONBC half of the protein obtained was 
subjected to UV irradiation.  For the GST-TC-WT, and each of the ONBC proteins (+/- 
UV irradiation), approximately 2 µM of appropriate protein used for labeling.  Protein 
was added to SDS loading buffer and subjected to 70 oC for 10 min.  FlAsH dye (in 
DMSO) was then added to a final concentration of 0.5 µM, and allowed to incubate at 70 
oC for 3 min.  All samples were then loaded onto an SDS-PAGE gel.  The SDS-PAGE 
gel was scanned in fluorescence mode Blue (450 nM)/ 520 LP, 1000 V, on high 




the reaction solution 3.5 µM tris(2-carboxyethyl)phosphine (TCEP), 10 µM EDT, 1 µM 
FlAsH, 0.5 µM protein, in 100 mM MOPS (pH 7.2) was used (final concentrations 
listed).  Each labeling reaction was allowed to incubate at room temperature for 1 hour 
prior to scanning.  The emission scan was set for an excitation of 508 nm and scanned 
from 510-600 nm (Ex slit 10.0 nm, Em slit 5.0 nm, PMT voltage 950 v, Hitachi F-4500 
FL Spectrophotometer). 
3.3 Results and Discussion 
3.3.1 Light-activated labeling of TC-tagged protein 
 Fluorescence labeling with FlAsH occurs through four covalent bonds between 
the thiols of each cysteine with the two arsenic groups of the dye (see Figure 3-2).  This 
1,2-dithiol exchange for the four cysteines requires the ability of the side-chain sulfur to 
be reduced for the binding event to occur.  Any change in the i, i+ 1, i + 4, i +5 cysteine 
arrangement results in the loss of the ability to exchange thiols reducing the quantum 
yield by up to 500%118.  The introduction of a caging group on one of the essential 
cysteines should inhibit the ability of these exchange events.  
 To test this hypothesis the Schistosoma japonicum gene encoding glutathione-S-
transferse (GST) was PCR amplified such that it contained an N-terminal TC-tag and a 
C-terminal 6X-histidine tag for purification purposes.  In addition, four synthetic genes 
were created that contain amber stop codons (TAG) in place of either Cys 1, 2, 5, or 6 of 
the TC-tag (using amino acid numbering in the actual tag).  These five genes were then 
expressed from the yeast expression vector pYES2 in yeast carrying an aminoacyl-tRNA 
synthetase/tRNA pair specific for ONBC19.  The orthogonal tRNA/aaRS pair used in this 




under denaturing gel electrophoresis conditions, the fluorescent binding events were first 
established via SDS-PAGE followed by subsequent fluorescence imaging.  FlAsH-
protein binding, and thus fluorescence, should be visible at the correct molecular mass of 
the protein (~28 kDa).   
 As can be seen in Figure 3-4, fluorescence is observed for GST-TC carrying the 
wild-type tag with four cysteines.  No labeling is seen in protein bearing tags that are 
masked with ONBC indicating that these mutants are not effectively labeled with FlAsH, 
despite possessing three of the four cysteine residues.  When these same samples are 
irradiated with 365nm light for 15 min however, clear labeling of the proteins can be 
seen.  Negligible differences of intensity are seen, indicating that the activation ratio of 
the four mutants is essentially the same.  If any difference can be identified, it is that the 
protein containing the mutation in place of Cys 2 expresses at a higher level than the 
others, potentially due to codon context effects.  
 
Figure 3-4.  SDS-PAGE analysis of FlAsH labeling.  Top panel shows a Coomasie stained gel.  
Bottom panel shows the same imaged for fluorescence (excitation 450 nm).  Protein samples 
contain a TC tag or a caged tag with the location of the unnatural amino acid mutation shown.  -





 These results verify that all four cysteine residues are essential for the proper 
alignment and association of the arsenical compound within the binding domain and that 
the introduction of a caging group blocks one thiol-arsenic exchange.  It is believed that 
the rigid nature of the complex between FlAsH and the TC-tag actually inhibits a 
quenching mechanism that occurs when the compound is in complex with EDT.  As 
expected, the introduction of one ONBC molecule at an essential cysteine blocks the 
exchange events of an arsenic atom on the compound.  This was observed at all four 
potential cysteines indicating that all four residues are required for the fluorescent 
labeling.  Even if the free cysteines (three remaining non-caged residues) are open to 
undergo chemical interactions, inhibition of fluorescence is observed due to the inability 
of all four cysteines to form the constraints required to hinder quenching.  Photolysis of 
the caging group is promoted by irradiating with 365 nm affording native cysteine, 
facilitating the binding of the FlAsH dye.  This confirms the ability to control the 
fluorescent labeling of a TC-tag with FlAsH dye leaning to the notion that this technique 
may become a powerful application in spatiotemporal control of cellular imaging.                
3.3.2 Fluorescence quantification 
In order to quantify this activation of protein labeling, purified protein was used to 
measure the fluorescence intensity derived from the TC-biarsenical complexes following 
the thiol exchange reaction.  Purified protein was again subjected to irradiation (where 
half was not introduced to decaging events) and was added to an MES buffer solution 
containing 10 μM EDT and 1 μM FlAsH compound.  The specificity of FlAsH binding is 
improved by the addition of EDT to the solution119 because it reduces nonspecific 




O) compounds for which the motif binding site was based.  The labeling was allowed to 
incubate at room temperature for one hour as fluorescence increases rapidly but requires 
time to reach maximum levels.  An emission scan was performed to determine the 
fluorescent counts for each labeling event.  Concurrent with the data observed for the 
SDS-PAGE, there was a significant increase in fluorescence (~1000 fold at these 
concentrations, Figure 3-5) upon decaging for those proteins containing the unnatural 
amino acid, a value comparable to previous examples using FlAsH.  The nonfluorescent 
FlAsH compound has been reported to increase fluorescence by up to 50000 times upon 
tetracysteine binding, where we observe a nearly 1000 fold increase, similar to that 
reported for the optimized sequence, FLNCCPGCCMEP (H2N-Phe-Leu-Asn-Cys-Cys-
Pro-Gly-Met-Glu-Pro-CONH2)127.  Again, there appears to be no apparent difference in 
the activation ratio between the four positional mutants, indicating that the presence of 






Figure 3-5.  Emission scan of TC-tagged proteins (excitation 508nm).  The baseline traces are 




 In summary, it has been shown that the ubiquitous FlAsH labeling event can be 
controlled with photo-caged unnatural amino acids.  This represents an attractive 
alternative to PA-GFP tagging that is smaller, and less likely to disrupt protein function.  
In addition to FlAsH, several other derivatives of biarsenical dyes have been reported 
including the red dye ReAsH118, opening the possibility for multicolor imaging.  Indeed 
this approach might facilitate sequential labeling of multiple TC tags on the same protein 
or within a cell.  Further biarsenical chemistry has recently been used for purposes 
outside of simple fluorescence labeling such as site-specific bioconjugations and even 











Chapter 4: Site-specific incorporation of 2-fluorotyrosine into E. 
coli via photochemical disguise 
4.1 Introduction 
 Fluorinated amino acids are powerful tools that have been used to investigate 
protein structure and function.  Importantly, the small size of the fluorine atom is 
expected to not perturb the protein structure, while its high electronegativity and NMR 
active nuclear spin enable its application as a very precise biological probe.  When 
incorporated into a protein, the fluorine atom provides a unique resonance for structurally 
investigating selected regions of a protein using 19F NMR spectroscopy.  The chemical 
shielding of this nucleus is highly responsive to the molecular environment and can 
report on protein conformational changes, and thus folding and unfolding processes129. 
19F NMR experiments benefit from the high sensitivity and 100% natural abundance of 
the 19F isotope, thus minimizing complications by background signals from non-labeled 
biomolecules.  The sensitivity is such that it can even be used to track proteins in vivo 
using live cells as the NMR sample59. Depending on the amino acid used, the structural 
disruptions to a protein can be minimized as fluorine is a conservative substitute for 
hydrogen atoms.  Indeed, fluorinated analogues of tyrosine, histidine, phenylalanine and 
tryptophan have all been incorporated into proteins for this purpose. However, proteins 
containing extensive fluorination can behave differently,130  and assignment of 19F 
resonances in large proteins becomes increasingly complex with increasing numbers of 
fluorinated residues.   
In addition to being an excellent NMR probe, the high electronegativity of 




site.  As discussed in Chapter 1, the pKa of the tyrosine phenolic proton is approximately 
10, but the pKa of fluorotyrosines can range from 5.2-9.0 depending on the extent of 
fluorination131, 132.    Therefore, the acidity of individual side chains within a protein can 
be precisely modulated to investigate the participation of a given residue in acid/base 
catalysis mechanisms.  The same is true of the redox properties of tyrosine residues64.  In 
the study of biologically generated tyrosyl radicals, there are no structurally similar 
amino acids with alternative reduction potentials in the genetic code.  Fluorotyrosines 
have peak reduction potentials that range from 705-968 mV, depending upon the extent 
and position of fluorination.  This allows fluorotyrosines to be used as comparison probes 
to tyrosine, which has a peak potential of 642 mV64. 
The main limitation preventing the extensive utilization of fluorinated amino 
acids in the investigation of enzyme function is the process by which they are currently 
being introduced into proteins, as it is challenging to achieve a site-specific incorporation, 
while still obtaining significant amounts of protein.  Due to the similarities of fluorinated 
and natural amino acids in size and shape – fluorine has only a 0.15 Å larger van der 
Waals radius than hydrogen – fluorinated amino acids are often introduced into proteins 
via global incorporation when introduced to cells.  For example, when culturing E. coli 
cells starved of tyrosine in the presence of 2- or 3-fluorotyrosine, the fluorinated amino 
acids are incorporated into proteins in place of all tyrosine residues58, 133 (Figure 4-1).  
This process requires auxotrophic strains of E. coli and correct timing of the addition of 
fluorotyrosine to the media to prevent global incorporation into all cellular proteins.  The 
obvious concern for metabolic labeling is that there is no site-specificity and the sample 




in sample heterogeneity and could make it impossible to link functional consequences to 
a single residue. 
 
Figure 4-1.  General incorporation of 2-fluorotyrosine, which is recognized by the endogenous 
tyrosyl machinery, encoding fluorotyrosine throughout the protein at all UAC codons.   
 
Several attempts have been made to combat this problem of poor site-selectivity.  
Homogeneous proteins containing fluorotyrosines have been produced by a combination 
of chemical peptide synthesis and expressed protein ligation132. Unfortunately, this 
approach is limited to certain locations within a protein, typically at the C-terminus, and 
can be technically challenging for proteins that are sensitive to denaturation.  Previously 
unnatural amino acid mutagenesis has been performed in an in vitro protein expression 




fluorotyrosines134.  This approach is limited by the requirement for a laborious synthesis 
of the aminoacylated tRNA and the small protein yields typically obtained.    
A more versatile method would be to use in vivo unnatural amino acid 
mutagenesis based on an orthogonal aminoacyl-tRNA synthetase (aaRS)/tRNA enabling 
a protein expression in E. coli.135 This would limit the amount of site-specifically 
fluorinated protein obtainable only by the size of the bacterial culture and enable the 
protein production using standard molecular biology techniques.  Such an approach, 
however, is complicated by the fact that NAAs that are similar in structure to endogenous 
amino acids infiltrate cellular protein biosynthesis.  As a solution to this problem, the 
NAA acid is temporarily converted to a full UAA by the addition of an o-nitrobenzyl 
group.  This in turn, masks the fluorinated amino acid from the cellular metabolism using 
a photo-removable protecting group34, 35, 136 (Figure 4-2).  A chemoenzymatic synthesis 
of ortho-nitrobenzyl-2-fluorotyrosine (4-1) was performed for introduction of this amino 





Figure 4-2.  Amber suppression for the site-specific incorporation of o-nitrobenzyl-2-




4.2.1  Materials 
 Reagents for the synthesis of 2-fluorotyrosine, o-nitrobenzyl-2-fluorotyrosine (4-
1), and o-nitrobenzyl tyrosine (4-2) were purchased from Fisher.  All other reagents were 
purchased commercially and used without further purification.  All enzymes were 
purchased from New England Biolabs and Fermentas.  Sequencing was performed at the 
University of Maryland at the Center for Biosystems research.  The positive and negative 
selection plasmids, as well as pSUP-ONBY, was supplied by Dr. Peter Schultz (The 




tyrosine phenol-lyase, was supplied by Dr. Robert S. Phillips (University of Georgia, 
Athens, GA).   
4.2.2 General Methods 
 The antibiotics employed were kanamycin (25 μg mL-1), tetracycline (25 μg mL-
1) and ampicillin (100 μg mL-1).  PCR reactions were performed with Taq DNA 
polymerase under the following conditions for 30 cycles:  95 °C for 30 s, 55 °C for 30 s, 
72 °C for 4 min.  DNA isolations were performed using Zyppy miniprep kits (Zymo 
Research).  Ligations were performed using T4 ligase under standard conditions.  All 
library transformations were performed into DH-10B electro-competent cells using ~100 
ng of DNA transformed into 100 μL of cells.  Standard transformations for plasmid 
amplification were performed into GeneHogs (Invitrogen) electro-competent cells using 
~100 ng of DNA transformed into 100 μL of cells.  4-1 and 4-2 were dissolved in 50% 
DMSO in water (v/v) with 0.5 M NaOH added dropwise until fully dissolved at ~80 °C.  
The solution of amino acid was then added to hot agar (or liquid) with stirring and 
allowed to cool to 40 °C before the addition of antibiotics (and cells for expressions).  
Denaturing discontinuous sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) gels (12% acrylamide resolving and 5% acrylamide stacking) and 1X 
Laemmli buffers were used following standard procedures, performed at 200 V for 65 
min.  Purification of protein was performed using Probond Purification resin (Invitrogen) 
according to the manufacturer’s protocol for native isolation.  SDS-PAGE gels were 
stained with Coomassie Brilliant Blue.  GMML media was composed of the following:  
1.5% water agar, 1 % glycerol, 1 X M9 salts, 1 mM MgSO4, 0.1 mM CaCl2, and 0.3 mM 




nitrobenzyl group, a hand-held 100W Blak Ray lamp was used at a distance of 5 cm, at 4 
oC, for 30 min.  Emission scans were set for an excitation of 482 nm for 4-1 and 490 nm 
for 4-2.  Scanned was performed from 500-650 nm (Ex slit 10.0 nm, Em slit 5.0 nm, 
PMT voltage 950 v, Hitachi F-4500 FL Spectrophotometer). 
4.2.3  Synthesis of o-nitrobenzyl-2-fluorotyrosine  
 o-Nitrobenzyl-2-fluorotyrosine (ONB-2FY) was synthesized from 3-fluorophenol 
and characterized as previously described62.  Tyrosine phenol-lyase was utilized to 
enzymatically manufacture ONB-2FY.  The enzyme was over-expressed from the 
plasmid pTZTPL which housed the gene for the protein.  The cell pellet was resuspended, 
and then lysed, in the following buffer: 0.1 M potassium phosphate, pH 7.0, 0.1 mM 
pyridoxal phosphate, imM EDTA, and 5 mM β-mercaptoethanol.  The cellular debris was 
centrifuged, and the soluble fraction was added to a 1 L aqueous reaction containing the 
following: 3-fluorophenol (5 g, 44.6 mmol), pyruvic acid (60 mM), pyridoxyl-5’-
phosphate (10 mg L-1), ammonium acetate (30 mM), and β-mercaptoethanol (5 mM).  
The reaction was performed for approximately 5 days at room temperature in the dark. It 
was monitored by HPLC for the disappearance of phenol (tR ~15 min) and the appearance 
of the product (tR ~ 4 min).  The solution was then purified by ion exchange to afford 
ONB-2FY.  1H NMR (400 MHz, D2O); δ 6.88 (dd, J = 10.17 Hz, J = 8.32 Hz, 1 H), 6.31 
(dd, J = 8.32 Hz, J = 2.31 Hz, 1 H), 6.23-6.27 (m, 1 H), 3.35 (dd, J = 7.40 Hz, J = 5.55 
Hz, 1 H), 2.81 (dd, J = 13.87 Hz, J = 5.55 Hz, 1 H), 2.64 (dd, J = 13.87 Hz, J = 7.40 Hz, 
1 H).  HRMS (ESI) m/z calculated for C9H10NO3F, 199.0645, found 199.0441.        
The o-nitrobenzyl protecting group was installed similar to reported methods137.  




(2.03 g, 50.8 mmol) in water.  CuSO4 (1.35 g, 8.47 mmol) was dissolved in 5 mL of 
water, separately.  These two solutions were equilibrated to 60 °C and then the CuSO4 
solution was added to the stirring solution of 2-fluorotyrosine.  The reaction mixture was 
maintained at 60 °C for 15 minutes.  The solution was then allowed to cool to room 
temperature and the pH was adjusted to 7.0 using acetic acid.  The precipitate was gravity 
filtered, washed with water, and dried under vacuum.   This afforded the copper complex 
Cu(2FY)2 (3.35 g, 86.2%).  The Cu(2FY)2 (3.35g, 7.29 mmol) complex was dissolved in 
a 200 mL solution of 75% DMF in water (v/v) and K2CO3 (2.02 g, 14.6 mmol).  2-
Nitrobenzylbromide (3.15 g, 14.6 mmol) was added and the reaction stirred for 48 hours 
at room temperature in the dark.  The precipitate was gravity filtered and then washed 
with 75% DMF in water (v/v) followed by cold 1 N HCl and water.  This product was 
then stirred in 100 mL of 1 N HCl for two hours at room temperature in the dark.  The 
amino acid was re-crystallized from 8:1 water/ethanol (v/v) with a couple drops of 1 N 
HCl to afford the desired white crystalline product (2.73 g, 61%, 53% overall). 1H NMR 
(400 MHz, DMSO); δ 8.13 (d, J = 8.5 Hz, 1 H), 7.76-7.81 (m, 2 H), 7.62-7.66 (m, 1 H), 
7.25 (t, J = 9 Hz, 1 H), 6.92 (dd, J = 12 Hz, J = 2 Hz, 1 H), 6.82 (dd, J = 8.5 Hz, J = 2.5 
Hz, 1 H), 5.46 (s, 2 H), 3.33 (bs, 3 H), 3.12 (dd, J = 14.5 Hz, J = 6.0 Hz, 1 H), 2.87-2.93 
(m, 1 H).  HRMS (ESI) m/z calculated for C16H15N2O5F, 334.0965, found 334.0956.  
4.2.4 Directed evolution of aa-tRNA synthetase specific for ONB-2FY 
 An active site library of M. janaschii aminoacyl-tRNA synthetases was 
constructed on plasmid pBK which encodes the gene for Mj YRS under the control of the 
Escherichia coli GlnRS promoter and terminator.  For the library the following amino 




possible amino acids (NNK codon); Tyr32 to all amino acids except Trp, Phe, Tyr, or 
Cys (VNK codon); Asp158 was limited to Gly, Ile, Ser, or Val (RKY codon); Leu162 
was limited to all polar amino acids (VRK codon).  The codes used above for the 
randomization of specific bases are as follows: N, all possible amino acids; K, only the 
bases G or T; V, only the bases A, C, or G; R, only the bases A or G; and Y, only the 
bases C or T.  Four rounds of sequential enzymatic inverse PCR were performed to 
obtain the library with the product of one round serving as the template for the next 
round.  The following primers were used for each round in which a unique BsaI site was 
introduced to each (italics): Round 1 (Tyr32) FWD 5’- GCG CAG GAA AGG TCT CAG 
AAA AAT CTG CTV NKA TAG GTT TTG AAC C and REV 5’ – GCG CAG AGT 
AGG TCT CAT TTC ATC TTT TTT TAA AAC CTC TCT TAA CTC TTC C; Round 2 
(Phe108) FWD 5’ – GCG CAG GAA AGG TCT CAG GAA GTG AAV NKC AGC TTG 
ATA CGG ATT ATA CAC and REV 5’ – GCG CAG AGT AGG TCT CAT TCC ATA 
AAC ATA TTT TGC CTT TAA CCC C; Round 3 (Asp158, Ile159, Leu 162) FWD  5’ –
GCG CAG GAA AGG TCT CAC CAA TAA TGC AGG TTA ATR KYN NKC ATT 
ATV RKG GCG TTG ATC TTG C and REV 5’ – GCG CAG AGT AGG TCT CAT 
TGG ATA GAT AAC TTC AGC AAC CTT TGG; Round 4 (Leu65, His70) FWD 5’ – 
GCG CAG GAA AGG TCT CAG ATA TAA TTA TAN NKT TGG CTG ATT TAN 
NKG GCT ATT TAA ACC and REV 5’ -  GCG CAG AGT AGG TCT CAT ATC AAA 
TCC AGC ATT TTG TAA ATC AAT C.  The purified PCR products were treated with 
DpnI to remove the parental DNA.  The enzyme BsaI was then used to digest the 
products, which were then ligated, and transformed into E. coli.  The obtained library size 




selection cells containing a plasmid (pREP2/YC-JYCUA) encoding a mutant 
MjtRNATyrCUA, the gene encoding chloramphenicol acetyltransferase gene with an in-
frame TAG stop codon, and the gene T7 RNA polymerase also containing an in-frame 
TAG stop codon which drives expression of a T7-controlled copy of green fluorescent 
protein, and a tetracycline resistant marker84. 
   The selection cells containing the library were grown in LB supplemented with 
Kan and Tet to a final OD600 = 0.8.  1 mL of these cells was plated on four 150 mm plates 
containing GMML agar supplemented with Tet, Kan and Chl, 0.002% arabinose and a 
final concentration of 1 mM 4-1 or 4-2 (Scheme 4-1).  These plates were incubated at 37 
oC for 48 hrs in the dark and then the cells collected and plasmid DNA isolated.  The 
pBK library was purified via gel electrophoresis.  The DNA was then transformed into 
negative selection cells containing a mutant tRNATyrCUA, with a TAG stop codon in the 
barnase gene under control of an arabinose promoter and rrnC terminator, and an 
ampicillin resistance marker.  These transformations were plated on LB agar containing 
Amp and 0.002% arabinose.  Following incubation at 37 °C for 24 hrs, the cells were 
collected, the library DNA isolated and purified by gel electrophoresis.  The DNA from 
the negative selection round was transformed back into positive selection cells and plated 
as described above for the first round of positive selections only with 90 μg mL-1 
chloramphenicol.  After two rounds of positive and negative selection, individual 
colonies were inoculated into a 96-well block and grown in LB media containing Tet and 
Kan.  The cells were screened on GMML Agar supplemented with Tet, Kan and Chl 35 
µg mL-1, 0.002% arabinose and a final concentration of 1 mM of 4-1 or 4-2.  Two 




and the DNA from these single colonies was isolated and sequenced.  The gene encoding 
ONB-2FYRS-1, which was used for all protein expressions, was excised with PstI and 
NdeI and ligated into the same sites of pSup138, to generate pSup-ONB-2FYRS-1.   
4.2.5 Expression of sfGFP  
 pSup-ONB-2FYRS-1 was transformed into E. coli cells along with pTrc-HisA-
sfGFP66TAG (or pTrc-HisA-sfGFP150TAG for mass spec studies) (See appendix for 
plasmid construction).  These expressions were performed in 2X-YT media (50 mL) 
supplemented with Amp, Chl, and a final concentration of 1 mM of 1.  The cells were 
grown to an OD600 = 0.8 and then induced with a final concentration of 1 mM IPTG.  
Expression was continued at 37 °C, overnight in the dark.  Purification of sfGFP was 
performed using the HisLink purification system (Promega) under native conditions 
according to the manufacturer’s protocol.  Isolated protein was then dialyzed against 20 
mM TRIS buffer (pH 7.2), analyzed via SDS-PAGE electrophoresis, and used for 
fluorescence experiments.   
 
4.3 Results and Discussion 
4.3.1  Synthesis of ONB-2FY and substrate recognition with pSUP-ONBY  
For protein expression multi-gram quantities of ONB-2FY (4-1) were needed and 
therefore it was decided to produce the amino acid using a combination of chemical and 
enzymatic synthesis.  In addition to being scalable, the procedure can be easily adapted to 
make other fluorotyrosine analogues.  Using 3-fluorophenol as the starting material 
enantiomerically pure 4-1 was synthesized using the enzyme tyrosine phenol lyase139 and 




alkylation with 2-nitrobenzylbromide resulting in the desired amino acid containing a 
photo-removable protecting group (Scheme 4-1).  With sufficient amino acid now 
synthesized, expressions were performed in the presence of this compound, with genes 
containing a mutation at a position determined by the amber stop codon mutation, TAG. 
 
Scheme 4-1.  Synthesis of ONB-2FY.  The addition on o-nitrobenzyl bromide was also applied to 
tyrosine, where X is indicative of the species mentioned in this text.  The caging group is 
removed with exposure to 365 nm light.  Step one had a 74% yield, while step two had a 61% 
yield.   
 
Previously the Mj tyrosyl-tRNA synthetase was evolved to accept 4-2 as a 
substrate, suppressing the amber codon with the UAA20.  It was assumed that with such a 
small structural change to the substrate, 4-1 would be accepted by this enzyme and 
therefore the amino acid could be inserted into proteins using the previously described 
machinery.  This simple change of a single hydrogen to fluorine atom is indeed a 
conservative substitution since 2- and 3-fluorotyrosine are both substrates for the 
endogenous E. coli TyrRS, hence the requirement for photo-caging in the first place.   
Surprisingly, after repeated attempts to produce protein using ONB-YRS, 
expressions were unsuccessful.  This was indeed an unexpected result as there was no 
intent to have to evolve a new synthetase for suppression with 4-1.  Since this UAA 
would not act as a substrate for the ONB-YRS, the only alternative was the generation of 




4.3.2 Evolution of a tRNA/aaRS pair for the recognition of ONB-2FY 
 Taking advantage of the selection methods detailed in Chapter 1.3.2, a library was 
constructed in which the residues within the active site of the Mj YRS (Y32, L65, H70, 
F108, D158, I159 and Ll62) were randomized or selectively diversified yielding >108 
variants.  This library was built through successive rounds of inverse PCR, where each 
consecutive round acted as the template for the next.  These mutations were based on 
those, which were identified for the evolution of Mj YRS to recognize 4-2 (ONB-YRS), 
all of which are considered important residues in the active site binding domain (Figure 
4-3A). Y32 and D158 are especially critical as they form hydrogen bonds with the 
hydroxyl group of the cognate tyrosine.  Random mutations at these sites hoped to 
provide an expanded space for access of a larger amino acid, as well as displacing the 
hydrogen bond associations at the phenol.  The observed mutations in ONB-YRS were as 
follows:  Y32G, L65G, F108E, D158S, and L162E.  These mutations indeed disfavor the 
recognition of native tyrosine as the D158S and Y32G changes likely disrupt the 
hydrogen bonding needed for the substrate recognition.  As a caged group was introduced 
to the compound a larger active site is warranted for binding to the synthetase.  The 
Y32G and L65G mutations seem to fit this role and increase the size of the binding 
pocket to better house the bulky addition.  The compound to be selectively paired with a 
new aaRS has nearly equivalent structural identity with the mentioned system, so it was 
assumed that only slight mutations at the same positions would be necessary to facilitate 
this evolved recognition event.  It should be noted that the original ONB-YRS was 
derived from a library which did not include randomized positions H70 and I159, 
resulting in a slightly different starting pool of synthetase mutants.  These new 




the Mj YRS evolved to recognize pBpa (Figure 4-3b).  H70 sits directly adjacent to the 
phenylalanine benzene group when bound in the active site.  The electronic interactions 
between the imidazole group and the fluorine on the tyrosine could be too disruptive for 
binding events to occur.  Altering this site was thought to allow for less sterics.  The I159 
was mutated to help potentially open the binding pocket a little further.  In addition, these 
mutations are part of a large diverse library that selectively partitions for the best fit, so 





Figure 4-3.  Crystal structure of the binding pocket of (a) wild-type Mj TyrRS (PDB 1J1U), and 
(b) pBpa Mj TyrRS bound to pBpa, shown in blue (PDB 2HGZ).         
 
 
The new library was applied in a double-sieve selection designed to isolate a new 
enzyme that was capable of accepting 4-1 as a substrate, but no endogenous amino acids.  




suppression of a TAG codon in the gene encoding chloramphenicol acetyl transferase, 
and a T7-polymerase gene in direct control of a partnered GFP gene expression) in the 
presence of 4-1 and a negative selection (using a TAG codon in the toxic gene barnase) in 
the absence of 4-1, as described in Chapter 120.  After two rounds of positive selection 
and two rounds of negative selection, individual clones were screened for 
chloramphenicol resistance in a third positive selection, dependent on the presence of 4-1.   
Initial trials with this selection process appeared to have afforded plasmid 
synthetases which specifically recognize 4-1.  As can be seen in figure 4-4, there are 
several colonies which have survived the final positive selection round, growing only in 
the presence of 4-1, and at elevated levels of chloramphenicol.  These results indicated 
the suppression of the CAT gene as well as the gene encoding the T7-polymerase, as 
indicated by the green fluorescence of the cells.  The library plasmid DNA was isolated 
from these final survivors and sent for sequencing.  Again, data was obtained which was 
contrary to the expected assumptions.  Sequencing results for these library members 
proved unreasonable, where nearly all contained no sequence homology, or similarity to 
the previously evolved synthetase for 4-2.  This was surprising indeed, with the only 
explanation being that these synthetases survived the negative round selections, 






Figure 4-4.  Final positive selection round for the suppression of a T7-promoter and CAT gene in 
the presence of the 4-1.  The top row is grown in the absence of amino acid, while the bottom is 
in the presence of 1 mM, final concentration.     
 
At this point, there was apprehension over the fidelity of the library.  Even though 
sequencing results of the library DNA were correct, these unsuccessful attempts at 
selecting a synthetase for 4-1 was concerning.  To test the library it was selected against 
4-2, as previously described, to act as a marker for its integrity.  Following successive 
rounds of selections, nearly twenty colonies survived, where four of the plasmids were 
sent for sequencing.  Two of the sequencing results provided the desired synthetase 
sequence, with mutations as reported above.  Interestingly, two other sequences were 
returned which had only slight variations in the mutational residues which held 
precedence that perhaps the library of plasmids selected for against 4-2 would have the 
mutation of interest for recognizing 4-1.  With this, an alternative selection process was 
initiated where all the surviving colonies of the final negative round from a selection 
against 4-2 were then screened in the presence of 4-1.  This idea was rationalized by the 
fact that a similar two-step approach has proven useful in the past to modify substrate 





Figure 4-5.  Final positive selection round for the suppression of a T7-promoter and CAT gene in 
the presence of the 4-1, from previous rounds selected against 4-2.  Two surviving colonies were 
selected in the presence of chl 90 µg mL-1.     
 
 Indeed, two clones that grew on agar containing 90 μg mL-1 chl, in the presence 
of 4-1 but only 20 μg mL-1 with no exogenous amino acid (Figure 4-5).  Upon examining 
the sequence of these two aaRSs (ONB-2FYRS-1 and -2) it was determined that they 
were very close homologues of the previously evolved enzyme20.  A noticeable 
difference, however, was the presence of a F108G mutation in both clones.  This is 
contrasted with the original ONB-YRS, which contained a F108E mutation (Table 4-1).  
It is quite possible that this mutation to glycine results in a larger, more flexible active 
site capable of accepting the slightly larger fluorinated substrate.  In addition, the 
mutations of H70N or H70M were identified, and I159M, which could not have been 
identified in the previous study as those residues were not included in the original library 
for 4-2.  The mutations at H70 help justify a potentially disruptive interaction between 
the fluorine and rigid, electron rich imidazole ring when 4-1 is introduced to the original 




from the spatial arrangement near the fluorine atom.  What is most intriguing is that the 
natural E. coli TyrRS does not discriminate against fluorinated analogues despite being 
selected by evolution, while the engineered ONB-YRS does.  
Table 4-1.  Sequence comparison of evolved TyrRS synthetases. Differences from the original 
ONB-YRS sequence are indicated in red. 
  
To verify the site-specific insertion of 4-1 into a protein an over-expression of the 
gene encoding 6×-histidine tagged sfGFP with a TAG codon in place of residue V150 
was performed.  This was carried out using the variant ONB-2FYRS-1, sub-cloned into a 
pSUP plasmid138 for compatibility with our expression system.  The pSUP plasmid 
simultaneously harbors the orthogonal amber tRNA gene, enabling the ability to co-
express the pair of essential suppression elements in parallel.  Expression of full-length 
protein was observed when 4-1 was included in the growth medium at a 1 mM 
concentration (Figure 4-6).  The protein yield under these conditions is approximately 2 
mg L-1, which is comparable to protein expressions using 4-2 20.  In the absence of the 
unnatural amino acid, no production of full-length protein is observed, indicating a high 
fidelity of the evolved synthetase since it does not accept any endogenous amino acid as a 
substrate.  To further verify the correct product, an in-gel tryptic digest on the sfGFP 
protein was performed, where the isolated fragments were subjected to mass 




(Figure 4-6).  A comparison of the mass spectrometry analysis of sfGFP expressed with 
ONB-YRS in the presence of 4-2 and expressed with ONB-2FYRS in the presence of 4-1 
revealed identical peptide sequences for both proteins apart from those fragments 
containing the mutation which differ by a m/z of 18, equal to the difference of a fluorine 
and hydrogen atom.  The arrows in figure 4-6 indicate two ion fragments which differ by 





Figure 4-6.  Coomassie stained SDS-PAGE gel of purified sfGFPV150TAG following an 
expression in both the absence and presence of 1 mM 4-1.  Mass spectral analysis of tryptic 
fragments (top) bearing 4-1 and (bottom) bearing 4-2.  The b and y ions change for fragments 
containing the fluorinated tyrosine by a mass of 18 Da.  This is illustrated by the arrows at one 




4.3.3 Investigation of altered protein function through fluorescence studies 
 To test whether site-specific mutations of fluorotyrosine could be used to alter 
protein function the site-specific introduction of 4-1 was performed at an essential 
tyrosine in the chromophore of GPF.  Previously, global mutagenesis studies have given 
rise to altered activity, such as pH rate profiles, but these experiments used proteins 
containing multiple mutations.  One such study used global incorporation of 3-
fluorotyrosine into EGFP60, 133, which contains eleven total tyrosine residues.  One of 
these, Y66, is central to the chromophore.  In order to conduct a more precise 
investigation, sfGFP, an improved stability version of GFP141, was expressed and isolated 
in the presence of 4-1 (Figure 4-7 c-d).  This protein, unlike any previous studies, 
contains only a single residue mutation to a fluorotyrosine.  In addition, a control sfGFP, 
which instead contained 4-2, was also generated for comparison purposes as a surrogate 
for the wild-type tyrosine residue.  Both of these proteins were purified and then 
“decaged” by irradiation at 365 nm for 30 minutes, after which were assayed for 
fluorescence properties.  In the case of the fluorinated chromophore mutation the λem  is 
blue shifted (503 nm) when compared to the tyrosine control (513 nm) (Figure 4-7 a-b). 
This demonstrates the ability of a single fluorotyrosine residue to change the electronic 





Figure 4-7.  a) Normalized fluorescence of decaged protein containing 4-1 or 4-2. b) The actual 
fluorescence of protein containing 4-1 before and after irradiation at 365 nm for 30 minutes, 
showing activation levels.  c) The structure of sfGFP mature chromophore, shown in green.  PDB 
entry 2B3P.  d) The structure of the mature chromophore with a 2-flurotyrosine mutation at Y66.    
 
One interesting observation is that the sfGFP bearing 4-1 is fluorescent at 503 nm, 
and that this fluorescence increases by 343% after removal of the ONB caging group 
through a brief irradiation at 365 nm (Figure 4-7).  This increase in fluorescence is most 
likely due to the generation of the phenol hydroxyl group which can delocalize charge 
throughout the chromophore ring system, and is not possible when the amino acid is 




tyrosine of sfGFP, which is in the core of the protein, would be destabilizing to the 
protein.  Indeed, sfGFP is known to lose all fluorescence upon denaturation142.  Thus, the 
observation of fluorescence in the case of GFP containing 4-1 indicates that the large 
ONB caging group does not prevent correct protein folding and can be accommodated in 
the active site.  The photo-activation by the removal of a protecting group from the 
chromophore of the protein could be used as a general method to “switch” fluorescent 
proteins, and the fact that 4-1 and 4-2 are genetically encoded amino acids enables the 
possibility of using directed evolution to improve the photo-switching properties.   
4.3.4 Investigation of altered protein function through enzymatic studies 
 As an attempt to further explore the use of fluorinated tyrosine, it will be used as a 
probe to investigate its electronic nature in the active site of E. coli β-galactosidase.  The 
aim is to control tyrosine acidity within the context of an enzyme active site by 
incorporating 4-1 in place of Y503.  This tyrosine residue is critical for catalysis and 
previous studies have, shown that Y503 is important in orienting active site residues, 
including E537, and serving as a general acid143, 144 (Figure 4-8).  Global introduction of 
fluorotyrosines would surely alter statistical data, as there are 32 tyrosines in this rather 
large protein.  However, using the general approach of disguise, with photo-protecting 





Figure 4-8.  a) Structure of β-gal with the position of tyrosine mutation and catalytic glutamate 
shown in green, substrate in magenta. b) Schematic of the transition state for the regeneration of 
the free enzyme from the glycosylated enzyme intermediate. PDB entry 1JZ7. 
 
4.4 Conclusion 
 Previously, the investigation of tyrosines in protein, using fluorotyrosine 
substitutions, was limited by the global incorporation of this amino acid.  The general 
methodology described above enables individual tyrosines in proteins to be selectively 
mutated to 2-fluorotyrosine.  The concept of using a photo-removable protecting group to 
temporarily “hide” amino acids from the endogenous cellular biosynthetic machinery 
may be generally applicable to other fluorotyrosine analogues, or any other close 
analogue of one of the twenty genetically encoded amino acids.  Finally, it was intriguing 
to discover that the fluorescence of sfGFP containing the caged 2-fluorotyrosine in the 
chromophore active site was greatly reduced compared to wild-type sfGFP, but could be 
activated upon a brief irradiation at 365 nm.  This observation holds promise as a novel 
rational method for the creation of photo-activatable green fluorescent proteins for 






Chapter 5: Site-specific incorporation of other tyrosine 
derivatives into E. coli via photochemical disguise 
5.1 Introduction 
 The previous chapter outlined the general application of photo-disguising 2-
fluorotyrosine for efficient incorporation into protein at the amber stop codon.  It was 
originally assumed that the small perturbation on the molecule would not disrupt 
substrate recognition by the previously evolved synthetase for ONBY.  Due to the 
inability to express protein with this synthetase, a new synthetase was evolved to 
specifically recognize o-nitrobenzyl-2-fluorotyrosine (ONB-2FY).  There are several 
other fluorotyrosine derivates of interest, all of which warrant the ability to be site-
specifically introduced at the genetic level.  Each analogue possesses differing pKa 
values which can be used as probes for protein function, just as outlined above.   
For the rationale addressed in the previous chapter, 3-fluorotyrosine (5-1) and 2,6-
difluorotyrosine (5-2) cannot be directly introduced to proteins as they are recognized by 
the endogenous translational machinery responsible for charging a tyrosyl-RS.  These 
two NAAs are also not suitable candidates for UAA mutagenesis for this same reason.  
As the general method for masking NAAs proved successful with ONB-2FY, the same 
application was directly applied to both 5-1 and 5-2.  Each of these compounds were 
synthesized using a combination of chemical and enzymatic synthesis, and then caged in 
the same fashion as that for the 2-fluorotyrosine.  With the evolution of two new 
synthetases, which possess altered binding-pockets, it was assumed that these new spatial 
arrangements may be promiscuous, and in turn also accept the caged versions of both 5-1 




has been modified it was worth performing expressions with these new synthetases to 
examine their direct recognition of 5-3 and 5-4.  Suppression of the amber codon with 
these UAAs would expand the molecular toolbox with available NAAs for protein 
exploration.    
 




 Reagents for the synthesis of 3-fluorotyrosine, 2,6-difluorotyrosine, o-
nitrobenzyl-3-fluorotyrosine (5-3), and o-nitrobenzyl-2,6-difluorotyrosine (5-4) were 
purchased from Fisher.  All other reagents were purchased commercially and used 
without further purification.  pSUP-ONB-2YRS-1 and -2 were employed from previous 
exploits. 
5.2.2 General Methods 
The antibiotics employed were chloramphenicol (35 µg mL-1) and ampicillin (100 
μg mL-1).  Transformations for were performed into GeneHogs (Invitrogen) electro-
competent cells using ~100 ng of DNA transformed into 100 µL of cells.  5-1 and 5-2 
were dissolved in 50% DMSO in water (v/v) with 0.5 M NaOH added dropwise until 
fully dissolved at ~80 °C.  The solution of amino acid was then added to hot agar (or 




cells for expressions).  Denaturing discontinuous sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) gels (12 % acrylamide resolving and 5% acrylamide 
stacking) and 1X Laemmli buffers were used following standard procedures, performed 
at 200 V for 65 min.  Purification of protein was performed using Probond Purification 
resin (Invitrogen) according to the manufacturer’s protocol for native isolation.  SDS-
PAGE gels were stained with Coomassie Brilliant Blue.  For samples subjected to UV 
irradiation, and subsequent loss of the o-nitrobenzyl group, a hand-held 100W Blak Ray 
lamp was used at a distance of 5 cm, at 4 °C, for 30 min.  Emission scans were set for an 
excitation of 490 nm.  Scanning was performed from 500-650 nm (Ex slit 10.0 nm, Em 
slit 5.0 nm, PMT voltage 950 v, Hitachi F-4500 FL Spectrophotometer). 
5.2.3 Synthesis of o-nitrobenzyl-3-fluorotyrosine and o-nitrobenzyl-2,6-
difluorotyrosine 
5-1 was synthesized from the starting material 2-fluorophenol and 5-2 was 
synthesized from the starting material 3,5-fluorophenol, where both were characterized as 
previously described in the previous chapter (4.2.3).   
3-Fluorotyrosine.  1H NMR (400 MHz, D2O); δ 6.79 (dd, J = 12.95 Hz, J = 2.31 
Hz, 1 H), 6.67-6.70 (m, 1 H), 6.59 (dd, J = 10.17 Hz, J = 8.32 Hz, 1 H), 3.33 (dd, J = 
7.40 Hz, J = 5.55 Hz, 1 H), 2.74-2.78 (m, 1 H), 2.85-2.63 (m, 1 H).  HRMS (ESI) m/z 
calculated for C9H10NO3F, 199.0645, found 199.0237.     
2,6-Difluorotyrosine.  1H NMR (400 MHz, D2O); δ 6.04-6.09 (m, 2 H), 3.32 (dd, 
J = 7.63 Hz, J = 6.01 Hz, 1 H), 2.77-2.82 (m, 1 H), 2.62-2.67 (m, 1 H).  HRMS (ESI) m/z 
calculated for C9H9NO3F2, 217.0550, found 217.0297.          
The o-nitrobenzyl protecting group was installed similar to reported methods137, 




o-Nitrobenzyl-3-fluorotyrosine.  1H NMR (400 MHz, DMSO); δ 8.14 (d, J = 
7.86 Hz, 1 H), 7.78-7.83 (m, 2 H), 7.62-7.66 (m, 1 H), 7.12-7.18 (m, 2 H), 6.99 (d, J = 
8.79 Hz, 1 H), 5.50 (s, 2 H), 3.36 (bs, 3 H), 3.06 (dd, J = 14.33 Hz, J = 4.62 Hz, 1 H), 
2.08 (dd, J = 14.33 Hz, J = 7.86 Hz, 1 H).  HRMS (ESI) m/z calculated for C16H15N2O5F, 
334.0965, found 334.0258.  
o-Nitrobenzyl-2,6-difluorotyrosine.  1H NMR (400 MHz, DMSO); δ 8.14 (d, J = 
8.03 Hz, 1 H), 7.74-7.81 (m, 2 H), 7.64 (t, J = 7.53 1 H), 6.84 (d, J = 9.54, 2 H), 5.48 (s, 
2 H), 3.35 (bs, 3 H), 3.06-3.19 (m, 2 H).  HRMS (ESI) m/z calculated for C16H14N2O5F5, 
352.0871, found 352.0758.     
5.2.4 Expression of sfGFP 
 pSup-ONB-2FYRS-1 (or -2) was transformed into E. coli cells along with pTrc-
HisA-sfGFP66TAG (or pTrc-HisA-sfGFP150TAG for mass spec studies) (See appendix 
for plasmid construction).  These expressions were performed in 2X-YT media (50 mL) 
supplemented with Amp, Chl, and a final concentration of 1 mM of appropriate amino 
acid.  The cells were grown to an OD600 = 0.8 and then induced with a final concentration 
of 1 mM IPTG.  Expression was continued at 37 oC, overnight in the dark.  Purification 
of sfGFP was performed using the HisLink purification system (Promega) under native 
conditions according to the manufacturer’s protocol.  Isolated protein was then dialyzed 
against 20 mM TRIS buffer (pH 7.2), analyzed via SDS-PAGE electrophoresis, and used 
for fluorescence experiments. 
5.3 Results and Discussion 
 To test the substrate recognition of both 5-3 and 5-4, protein expressions were 




both of the newly evolved synthetases, evaluating the efficiency of each.  The 
expressions were performed with sfGFP, as previously described.  
 Expression of full-length protein was observed when 5-3 was included in the 
growth medium at a 1 mM concentration when paired with either the ONB-2FRS-1, or -
2, synthetase (Figure 5-2).  In the absence of the unnatural amino acid, no production of 
protein was observed, indicating a high fidelity of binding interactions with 5-3.  It 
appears however, that 5-4 is only recognized as a substrate for the ONB-2FRS-2 
synthetase (Figure 5-2).  When 5-4 was included in the growth medium for expression 
with RS-1, there is no observed isolation of protein.  Full-length protein is indeed 
observed for the expression with RS-2.  Again, in the absence of the unnatural amino acid 
with RS-2, no production of protein was determined.  Although RS-2 appears to 
recognize both 5-3 and 5-4, the efficiency of protein expression seems impaired.    
 
Figure 5-2.  Coomassie stained SDS-PAGE gels of isolated protein expression for sfGFP.  Both 
gels represent protein expressed in the presence of the indicated amino acid, where the negative 
sign represents no addition of amino acid.  a) performed with ONB-2FYRS-1 and b) with ONB-
2FYRS-2.   
 
 To further verify the correct product, an in-gel tryptic digest on the sfGFP protein 




spectrometric sequencing confirming the site-specific incorporation of the two 
fluorotyrosines (Figure 5-3).  A comparison of the mass spectrometry analysis of sfGFP 
expressed in the presence of 5-3 and 5-4 revealed identical peptide sequences for both 
proteins apart from those fragments containing the mutation which differ by a m/z of 18, 
equal to the difference of a fluorine and hydrogen atom, as the di-fluoro and 3-fluoro 
derivatives have a single fluorine variation.  When these results were compared to the 
mass spectral data for ONB-2FY in the previous chapter, the masses were identical to 
those with 5-3, where the only variation between these two molecules is the position of 
the fluorine atom.  As expected, a mass differences of m/z = 36 was observed when the 





Figure 5-3.  Mass spectral analysis of tryptic fragments of sfGFP (top) bearing 5-1 and (bottom) 
bearing 5-2.  The b and y ions change for fragments containing the 5-1 by a mass of 18 Da and 36 
Da for fragments containing 5-2, as compared to native tyrosine.  The arrows at one ion fragment 
y(10), are illustrated here, where the y fragmentation for protein containing 5-1 is 18 Da heavier 
than that for protein with 5-2, due to difluorination of the tyrosine.          
 
 To further evaluate the potential of 5-3 and 5-4, these amino acids were 




expressions were purified and then “decaged” by irradiation at 365 nm for 30 minutes, 
after which they were assayed for fluorescence properties.  For the 2-fluoro chromophore 
mutation the λem was shifted from the wild-type 513 nm to 503 nm.  For the 3-fluoro 
chromophore mutation the λem was red shifted from 513 nm to 515 nm (Figure 5-4).  This 
is a rather conservative change indeed, but is consistent with previous data for the red 
shifting of 3-fluorotyrosine by 2 units in EGFP62.  The ability to induce fluorescence 
intensity upon UV irradiation was also observed for the 3-fluoro protein, as previously 
determined for the 2-fluoro derivative.  sfGFP bearing 5-3 is fluorescent at 515 nm and 
the fluorescence increases by nearly 500% after removal of the ONB caging group 
(Figure 5-4).  This data is consistent with that of the previous decaging events with ONB-
2FY further justifying the possibility that the photo-activation of the protein could be 
used as a general method to control fluorescent proteins in cells providing a level of 
spatiotemporal control.    
 
Figure 5-4.  a)  Normalized fluorescence of decaged protein containing 4-1, 4-2, and 5-1.  Also 
displayed is the normalized fluorescence of protein containing 5-1, before and after decaging (the 
caged fluorescence was adjusted against the peak fluorescence observed for the decaged sample).   
 
Although protein was isolated for the expression in the presence of 5-2, 




and 3-fluoro proteins, prior to decaging events.  No increase in fluorescence occurred 
following irradiation with 365 nm light.  It is believed that the di-fluoro addition to the 
critical tyrosine position may cause destabilizing effects in the chromophore of the 
protein.  If the new polarization interferes with the covalent formation of the 
chromophore, no fluorescence would be expected. 
 As this is a continuing project, the activity of β-gal is currently being probed by 
the site-specific insertion of 5-3 and 5-4 at the active site Y66.  These mutants will be 
applied to enzymatic assays as described in the previous chapter to determine the pH rate 
profiles for each fluorinated derivative.   
5.4 Conclusion 
 The concept of using a photo-removable protecting group to temporarily mask 
amino acids from the endogenous cellular biosynthetic machinery may be generally 
applicable to any near-natural analogues of amino acids.  It has been demonstrated here, 
with three fluorinated derivatives of tyrosine that the covalent modification of the 
phenolic hydroxyl group can act as a bypass mechanism for which UAA mutagenesis can 
be applied.  Once these compounds have been utilized in protein expression they can be 
photo-activated to become powerful probes in protein explorations.  While a fluorinated 
caged tyrosine was not recognized by the synthetase for its cognate non-fluoro partner, 
several fluorinated caged compounds seem to be recognized by newly evolved 
synthetases.  Where there are two distinctly different synthetases which recognize both 
ONB-2FY and 5-3, only one of them recognizes 5-4.  Since there is some promiscuity in 
these binding sites, it is worth exploring other fluorinated tyrosines with these newly 




also bind derivatives such as ONB-3,5-diFY, and ONB-2,3,5,6-tetraFY, the latter of 
which has a significant change in pKa at the phenol.  Not only may these compounds act 
as new tools for altering active site electronics, but the caging group generates the ability 




Chapter 6: Significance and Conclusion 
 
 With the advent of an expanding genetic code it is now possible to directly select 
for an amino acid of interest for protein translation at the genetic level.  The mutational 
selection system for an orthogonal amber-tRNA/aminoacyl-tRNA synthetase pair has 
revolutionized protein discovery through unnatural amino acid mutagenesis.  The 
growing number of these new additions to the genetic code each adds their own insight 
into biochemical function.  This work has taken advantage of these processes to exact a 
more precise chemical understanding of protein function with novel additions to the 
unnatural amino acid catalogue, as well as the expansion of techniques with previously 
developed compounds. 
 The overlapping theme of each compound utilized in this work is the ability to 
augment its native state with light.  This is a powerful weapon in the biological world as 
biochemical activity occurs as a cascade of cellular events which happen at specific 
intervals depending on the stimulus.  This spatial and temporal association is extremely 
difficult to monitor with typical biochemical assays.  Once an external agent is introduced 
to a system the control of a defined instance for its use is lost.  With the onset of 
photochemistry being applied to biological molecules it has become possible to 
manipulate amino acid side chains which contain photo-affinity labels, or photo-labile 
protecting groups, with the power of light.  In one instance, it becomes an invaluable tool 
for site-specific photo-crosslinking, and in the latter a potential “light switch” for 




act as a mask by which to introduce near-natural amino acids to protein, when disguised 
as an unnatural amino acid. 
  As mass spectrometric analysis is increasingly becoming paired with 
chemically cross-linked protein analysis, a major concern presents itself when trying 
to assign the cross-linked fragment of an unknown protein to a peak in the spectrum.  
Complex fragmentation patterns can often result from enzymatically treated 
complexes.  This work developed a new tool for the simplification of these analytic 
techniques during the use of unnatural amino acid mutagenesis, with an isotopically 
labeled analogue, [D11]-pBpa.  While isotopic labeling is widely used for mass 
spectral studies, this is the first example of this method with unnatural amino acids.  
The labeled derivative of pBpa creates a fingerprint during mass spectral analysis, 
clearly identifying a crosslinked peptide fragment of interest by the appearance of M, 
M +11 signature peaks in an array of masses.   
 The ability to control biological function with light is an intriguing application in 
biochemical studies.  There are many active biomolecules that have essential functional 
groups, all of which have the potential to be restricted in nature due to the addition of a 
photo-protecting group.  In the work accomplished here, a caged cysteine residue was 
introduced to a genetically encoded fluorescent affinity tag which is dependent upon four 
cysteine residues.  The compound 4,5-bis(1,3,2-dithioarsolan-2-yl)fluorescein, FlAsH, 
specifically binds to, and is activated by, the small amino acid tag sequence, CCPGCC.  
This occurs through a 1,2-dithiol exchange with the four cysteines in the tag.  It was 
shown that the ability of cysteine/dye reaction events was inhibited, due to the presence 




the FlAsH dye, and prohibited fluorescence.  When full-length protein was isolated, 
which contained ONBC in the tetracysteine tag, the direct control over small molecule 
binding to the protein was observed.  FlAsH labeling events could be manipulated with a 
photo-caged unnatural amino acid, as the fluorescence was restored following cysteine 
decaging with light irradiation.  This new application for the genetic encoding of ONBC 
could be an attractive alternative to other photo-activatable fluorescent proteins such as 
PA-GFP.    
 Near-natural amino acids are non-natural; however, they are only slight variants 
of their native structures.  The concern with these amino acids is that they are recognized 
by the endogenous aminoacyl-tRNA synthetase machinery that naturally incorporates the 
non-modified amino acid.  To circumvent this dilemma, these near-natural amino acids 
were temporarily disguised as unnatural amino acids, so as to be directly applied to the 
general method of unnatural amino acid mutagenesis.  As part of this work a new 
aminoacyl-tRNA synthetase was evolved to specifically recognize the fluorinated 
derivative of a caged 2-fluorotyrosine.  It was demonstrated that this fluorinated tyrosine 
could indeed be site-specifically introduced by first translating the protein with o-
nitrobenzyl-2-fluorotyrosine.  Subsequent illumination with light proved successful in the 
decaging of the molecule, affording protein with the site-specific placement of 2-
fluorotyrosine. 
 The newly evolved synthetase has also proven promiscuous to other fluorinated 
derivatives with the expression of protein in the presence of both a caged 3-fluorotyrosine 
and 2,6-difluorotyrosine.  This simple “deception” of introducing a photo-removable 




introduction of these amino acids to protein.   This opens the door for an array of new 
amino acids with powerful probing potential.   
 The direct expansion of any toolbox provides a wider range of options when 
attempting to elucidate problems of interest.  Chemically, there is an unlimited ceiling to 
the number of unnatural amino acids which can be synthesized for chemical studies.  
Each newly acquired chemical function can potentially be introduced to a protein through 
an expanded genetic code.   
 This work has spanned several disciplines including chemistry, biochemistry, and 
molecular biology.  The applications here should find a broad range of potential guests 
for further studies.  It is believed that this work has successfully focused on the synthesis 
and application of unnatural amino acids as a defined chemical approach in which to 
investigate protein function.  One of the major aspects of this work is the first attempt to 
use unnatural amino acid mutagenesis as a general approach to mask near-natural amino 
acids for their site-specific introduction to proteins.  This system provides the backdrop 
for an overwhelmingly large range of new small molecules (through synthetic generation 

















                                                   Appendices 
 
Other work addressed during this study 
 
 Selenocysteine: 
As discussed earlier, the site-specific encoding of selenocysteine is technically 
difficult as its natural codon is UGA, a universal stop codon, followed by a sequence 
Selenocysteine Insertion Sequence, SECIS, mRNA that specifically recruits cellular 
machinery required for selenocysteine incorporation.  Without the specific SECIS 
sequence there is no insertion of the amino acid.  These represent obvious molecular 
biological constraints when designing mutational expression sequences.  The site-specific 
incorporation of this amino acid during mutational studies is particularly appealing due to 
its reduced side chain pKa of 5.3.  This would not only help studies involving natural 
selenocysteine proteins, but also has the potential to be an attractive site for 
bioconjugations.   
 This amino acid is a near-natural analogue of cysteine; however, it is naturally 
occurring.  In a similar fashion to the work applied in the fluorotyrosine studies, a caged 
version of the amino acid was synthesized so as to be altered to an unnatural amino acid.  




protein expression was performed in the presence of caged selenocysteine, with the 
previously evolved synthetase which recognizes ONBC.  It was determined that caged 
selenocysteine was indeed a substrate for the ONBC synthetase when introduced for the 
over expression of human superoxide dismutase containing a TAG codon (Figure A-1).  
The protein is only fully expressed when in the presence of caged selenocysteine.  This is 
yet another example of how disguising amino acids with photo-removable protecting 
groups may act as a powerful method for the direct insertion of near-natural amino acids.  
Further exploration of this particular application needs to be pursued, as this indeed sets 
the basis for particularly interesting protein exploration. 
 
Figure A-1.  Coomassie stained SDS-PAGE gel of isolated hSOD protein which contains an 
amber codon in its gene.  Expressions performed with ONBC synthetase in the presence (+) and 
absence (-) of selenocysteine.  
 
Photo-induced protein function and site-specific cysteine labeling: 
Biological systems are dependent upon “switch” controlled protein function to 
transduce appropriate cellular responses.  Theses switches can range from small peptide 
ligands, to carbohydrates, to external stimuli such as light.  Artificial control of biological 
function allows for chosen activity by the researcher and not by nature.  Currently a 
system has been developed by which light can be used as a switch to activate protein 




which is a protein splicing element.  Inteins catalyze their own excision from a 
polypeptide chain, through cysteine protease type activity, subsequently joining the 
flanking exteins145-147.  A proteins function is generally disrupted prior to excision of the 
intein; however, excision is spontaneous and rapid upon complete translation of the 
protein.  Controlling the excision events of the intein presumably will allow for control 
over the function of the protein. 
 It was decided to apply the photo-caged system to an expression linked to an 
intein construct which contains the amber codon at the essential cysteine.  If a photo-
caged cysteine may be introduced, the caging group would act to inhibit intein excision, 
as it would block the nucleophilic ability of the thiol in the reaction mechanism.  Once 
the caging group was removed, via light, native cysteine would be afforded, activating 
the intein excision, “turning on” protein function (Figure A-2).  The expression vectors 
for this system have been created, and will be addressed in future studies.  Theoretically, 
it may be possible to extend a level of spatiotemporal control to protein function which 





Figure A-2.  General scheme of an intein based expression system where photo-caged cysteine 
may be used as a “switch” for posttranslational protein functionality. 
 
 In a similar fashion, photo-caged cysteine may prove to be an efficient tool for 
site-specific labeling with small molecules, or specific sites for bioconjugation reactions.  
If a protein contains multiple cysteine residues, the site of interested may be mutated to 
photo-caged cysteine, where the remaining cysteines (not already associated in a disulfide 




acid (Ellman’s reagent).  The protein can then be photochemically modified so that a 
single cysteine residue remains available for additional bioconjugation/modification 
reactions (Figure A-3).  In this general scheme it should be possible to site-specifically 
modify cysteine residues with tags such as polyethylene glycol (PEG).          
 
Figure A-3.  General scheme of potential site-specific labeling through the use of photo-caged 






 Experimental for ONBC control of intein function: 
 PCR Reactions and Homologous Recombination:  Three PCR reactions were 
performed to obtain the overlapping sections of a GFP-VMA-GFP construct.  VMA 
refers to the VMA intein from S. Cerevisiae, which was introduced as an insert, flanked 
by the N-term and C-term of the GFPuv gene.  The intein coding sequence replaced that 
of the amino acids 107-109 of GFP(uv).  The following primers were used to PCR 
amplify the N-terminal portion of GFP:  FWD – CCC GGA TCG GAC TAC TAG CAG 
CTG TAA TAC GAC TCA CTA TAG  GG AAT ATT AAG CTT ACC ATG AGT 
AAA GGA GAA GAA CTT TTC;  REV – TTC CAG CAC ACT GGC GGC CGT TAC 
TAG TGG ATC CGA GCT CGG TAC CGT AGT TCC CGT CAT C T TTG AAA GA.  
The red sequence represents the homologous overlapping sequence which matches that in 
the multiple cloning site of the expression vector used, pYES2 (Invitrogen).  The 
following primers were used to PCR amplify the C-terminal portion of GFP:  FWD – 
GCT GAA GTC AAG TTT GAA GGT GAT ACC CTT GTT AA; REV – ATT ACA 
TGA TGC GGC CCT CTA GAT GCA TGC TCG AGC GTT AAT GGT GAA TGG 
TGA TGG TGT TTG TAG AGC TCA TCC ATG CC (CL648).  The red sequence on the 
REV primer represents the homologous overlapping sequence which matches that in the 
multiple cloning site of pYES2, and the poly his-tag is underlined.  The plasmid 
pGFP(uv) was used as the template for both GFP amplifications with Phusion high-
fidelity polymerase (NEB).  The following primers were used to PCR amplify the VMA 
intein portion of the construct:  FWD – CAG GAA CGC ACT ATA TCT TTC AAA 
GAT GAC GGG AAC TAC GCG TGC TTT GCC AAG GGT ACC AAT GTT TTA 




AAG GGT ATC ACC TTC AAA CTT GAC TTC AGC TCG GCA ATT ATG GAC 
GAC AAC CTG GTT GGC AAG C.  The red sequence represents the homologous 
overlapping sequence which matches that of GFP, with the cysteine codons underlined.  
Yeast genomic DNA was used as the template for these PCR reactions with Phusion 
polymerase. 
Three different PCR reactions were performed to obtain the VMA mutants.  The 
following primers were used to PCR amplify VMA with the 5’- cys replaced by TAG 
(underlined):  FWD – CAG GAA CGC ACT ATA TCT TTC AAA GAT GAC GGG 
AAC TAC GCG TAG TTT GCC AAG GGT ACC AAT GTT TTA ATG G;  REV – 
TTA ACA AGG GTA TCA CCT TCA AAC TTG ACT TCA GTT AAC AAG GGT 
ATC ACC TTC AAA CTT GAC TTC AGC TCG GCA ATT ATG GAC GAC AAC 
CTG GTT GGC AAG C.  The following primers were used to PCR amplify VMA with 
the 3’-Cys replaced by TAG:  FWD – CAG GAA CGC ACT ATA TCT TTC AAA GAT 
GAC GGG AAC TAC GCG TGC TTT GCC AAG GGT ACC AAT GTT TTA ATG G; 
REV – TTA ACA AGG GTA TCA CCT TCA AAC TTG ACT TCA GCT CGC TAA 
TTA TGG ACG ACA ACC TGG TTG GCA AGC.  The following primers were used to 
PCR amplify VMA with both the 5’ and the 3’ terminal cys residues mutated to TAG:  
FWD – CAG GAA CGC ACT ATA TCT TTC AAA GAT GAC GGG AAC TAC GCG 
TAG TTT GCC AAG GGT ACC AAT GTT TTA ATG G; REV – TTA ACA AGG GTA 
TCA CCT TCA AAC TTG ACT TCA GCT CGC TAA TTA TGG ACG ACA ACC 
TGG TTG GCA AGC.  The red sequence represents the homologous overlapping 
sequences which match that of GFP.  pYES2-GFP-VMA was used as the template for 




Overlap PCR reactions were performed with all of the above VMA PCR products 
and the GFP(C) PCR product.  These reactions were carried out using 1 µL of each half 
reaction and the GFP(C) REV primer.  The FWD primer used was that which 
corresponded to the VMA introduced to PCR reaction.  The products obtained were 
VMA(WT)-GFP(C), VMA5’-GFP(C), VMA3’-GFP(C), and VMA3/5’-GFP(C), all of 
which were used in homologous recombination events. 
 
Homologous Recombination:  Homologous recombination was first performed 
using linearized pYES2 plasmid (digested with HindIII) cotransformed with the purified 
GFP(N) PCR product into InvSC cells.  The GFP(N) PCR product contained flanking 
overhangs homologous to the plasmid.  This recombination event gave pYES2-GFP(N), 
which contained the N-terminal portion of the GFP gene inserted into the expression 
vector.  The plasmid pYES2-GFP(N) was digested overnight with EcoRV to obtain 
linearized plasmid.  This was then transformed chemically into InvScI cells along with 
the overlapping PCR products mentioned above.  InvScI cells were inoculated in 100 mL 
of YPD media and grown to an OD600 = 0.80.  These cells were then spun down and 
washed three times with sterile water.  The cell pellet was resuspended in 1.5 mL of a 
lithium acetate solution (10 mM, Tris-HCl, 1 mM EDTA, 100 mM lithium acetate, pH 
7.5 in water).  To 100 µL of the cells was added 5 µL of linearized pYES2-GFP(N), 5 µL 
of the desired PCR product, and 600 µL of a PEG solution (10 mM, Tris-HCl, 1 mM 
EDTA, 100 mM lithium acetate, pH 7.5, in 50% PEG – 3500).  This solution was 
incubated at 30 oC for 30 min.  Following incubation, 70 µL of DMSO was added and 
mixed thoroughly via pipetting up and down.  This was then heat shocked at 42 oC for 15 




washed three times with 0.9% NaCl.  The pellet was then resuspended in 100 µL of 0.9% 
NaCl and the entire volume was plated on –uracil dropout agar media.  These plates were 
incubated at 30 oC for 48 hrs. 
 Colonies from these transformations were inoculated into –uracil dropout media 
and colony PCR was performed on each to determine if the correct recombination events 
had occurred.  The primers used for these PCR reactions were the GFP(N) FWD primer  
and the GFP(C) REV primer.  For those inoculations in which the correct products were 
observed, the DNA was then analyzed by the restriction enzymes HindIII and XbaI.  
Sequencing was then performed on all DNA consistent with the expected restriction 
sizes.  Sequencing results confirmed that the correct mutations were inserted. 
 


































































Construction of the sfGFP expression vectors 
    The gene encoding sfGFP was synthetically prepared by overlap PCR using 
homologous oligonucleotides.  Oligos 2 through 31 (see below) were combined in a 
reaction mixture under the following conditions; 0.2 mM of each dNTPs, 0.02 U/μL of 
DeepVent polymerase (NEB), 1 μM of each #2~#31 oligos, 20 mM Tris-HCl (pH 8.8 at 
25 ºC), 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4 and 0.1% Triton X-100 in 50 μL 




25 cycles of 95 ºC for 30 s, 57 ºC for 30 s and 72 ºC for 1 min and final extension at 72 
ºC for 10 min.  The synthetic gene was then amplified by PCR using oligos 1 and 32 in 
the following reaction; 1 μL of assembly PCR product, 0.2 mM of each dNTPs, 0.02 
U/μL of DeepVent polymerase (NEB), 1 μM of each #1 and #32 oligos, 20 mM Tris-HCl 
(pH 8.8 at 25 ºC), 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4 and 0.1% Triton X-100 
in 50 mL reaction, under the same cycle conditions.  The second PCR yielded a single 
DNA fragment which was digested with NheI and HindIII and was cloned into the same 
sites on the pTrcHisA vector (Invitrogen). 
The mutations to the sfGFP gene, 66TAG or 150TAG were performed via Quikchange 
mutagenesis with the corresponding oligos, Tyr66TAG-Fwd and -Rev or Val150TAG-
Fwd and -Rev, respectively.  The reaction conditions were; 2.4 ng pTrcHisA-sfGFP, 0.2 
mM of each dNTPs, 0.01 U/μL of Phusion polymerase (NEB) and 1X Phusion HF buffer 
in 20 mL reaction.  The following cycling conditions were used; initial denaturation at 98 
ºC for 30 s, 18 cycles of 98 ºC for 10 s, 58 ºC for 30 s and 72 ºC for 3 min and final 
extension at 72 ºC for 10 min.  This PCR product was digested overnight with DpnI and 
transformed into E. coli (DH-10B) to provide the correct mutations.  The identity of 
mutation was confirmed by DNA sequencing. 
Sequences of Oligonucleotides: 
#1: CTAgctagcATGATGAGCAAAGGCGAAGAACTGTTTACCGGCGTGGTTCCG 
(Nhe I) 
#2: ATCGCCATCCAGTTCCACCAGAATCGGAACCACGCCGGTAAA   
#3: GGTGGAACTGGATGGCGATGTAAATGGCCACAAGTTTAGCGT   




#5: GGGAAGGGGAGGGCGATGCGACCAATGGCAAACTGACCCTGA   
#6: TTCCCGGTCGTGCAAATAAACTTCAGGGTCAGTTTGCCATTG   
#7: GTTTATTTGCACGACCGGGAAACTGCCGGTTCCTTGGCCCAC   
#8: GCCATACGTCAGGGTGGTGACAAGGGTGGGCCAAGGAACCGG   
#9: CACCACCCTGACGTATGGCGTGCAATGCTTTAGCCGTTACCC   
#10: TCATGCCGCTTCATGTGGTCCGGGTAACGGCTAAAGCATTGC   
#11: ACCACATGAAGCGGCATGACTTCTTCAAAAGCGCCATGCCTG   
#12: CGTCCGTTCCTGAACATAGCCTTCAGGCATGGCGCTTTTGAA   
#13: GCTATGTTCAGGAACGGACGATCTCGTTTAAGGATGACGGCA   
#14: CCTCCGCACGGGTCTTATAGGTGCCGTCATCCTTAAACGAGA   
#15: CTATAAGACCCGTGCGGAGGTCAAATTCGAAGGCGATACCCT   
#16: TCAGCTCAATGCGGTTCACCAGGGTATCGCCTTCGAATTTGA   
#17: GGTGAACCGCATTGAGCTGAAGGGCATCGACTTCAAAGAGGA   
#18: TTGTGCCCCAGTATGTTGCCATCCTCTTTGAAGTCGATGCCC   
#19: GGCAACATACTGGGGCACAAGCTGGAGTACAACTTCAACAGC   
#20: GCGGTGATGTAGACGTTGTGGCTGTTGAAGTTGTACTCCAGC   
#21: CACAACGTCTACATCACCGCCGACAAGCAGAAGAACGGCATT   
#22: CCGAATCTTGAAGTTGGCCTTAATGCCGTTCTTCTGCTTGTC   
#23: AAGGCCAACTTCAAGATTCGGCACAATGTGGAGGACGGAAGC   
#24: GATAATGATCCGCCAGCTGAACGCTTCCGTCCTCCACATTGT   
#25: GTTCAGCTGGCGGATCATTATCAACAGAATACCCCCATTGGC   
#26: CCGGCAGAAGCACGGGACCGTCGCCAATGGGGGTATTCTGTT   




#28: ATTCGGGTCCTTGCTCAGCACGCTCTGGGTGCTCAAGTAATG   
#29: GCTGAGCAAGGACCCGAATGAGAAACGGGATCACATGGTGCT   
#30: CGCAGCGGTCACAAATTCCAGCAGCACCATGTGATCCCGTTT   
#31: GGAATTTGTGACCGCTGCGGGCATTACACATGGCATGGATGA   

















ESI Mass Spectrum for o-nitrobenzyl-2-fluorotyrosine 
 










ESI Mass Spectrum for o-nitrobenzyl-3-fluorotyrosine 
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